WO2003086538A1 - Mri-compatible medical device with passive generation of optical sensing signals - Google Patents

Mri-compatible medical device with passive generation of optical sensing signals Download PDF

Info

Publication number
WO2003086538A1
WO2003086538A1 PCT/US2003/010838 US0310838W WO03086538A1 WO 2003086538 A1 WO2003086538 A1 WO 2003086538A1 US 0310838 W US0310838 W US 0310838W WO 03086538 A1 WO03086538 A1 WO 03086538A1
Authority
WO
WIPO (PCT)
Prior art keywords
optical
electrical
sense signal
accordance
catheter
Prior art date
Application number
PCT/US2003/010838
Other languages
French (fr)
Inventor
Jeffrey T. Deal
Wilson Greatbatch
Original Assignee
Biophan Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophan Technologies, Inc. filed Critical Biophan Technologies, Inc.
Priority to AU2003228475A priority Critical patent/AU2003228475A1/en
Publication of WO2003086538A1 publication Critical patent/WO2003086538A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/24Coupling light guides
    • G02B6/26Optical coupling means
    • G02B6/28Optical coupling means having data bus means, i.e. plural waveguides interconnected and providing an inherently bidirectional system by mixing and splitting signals
    • G02B6/2804Optical coupling means having data bus means, i.e. plural waveguides interconnected and providing an inherently bidirectional system by mixing and splitting signals forming multipart couplers without wavelength selective elements, e.g. "T" couplers, star couplers
    • G02B6/2808Optical coupling means having data bus means, i.e. plural waveguides interconnected and providing an inherently bidirectional system by mixing and splitting signals forming multipart couplers without wavelength selective elements, e.g. "T" couplers, star couplers using a mixing element which evenly distributes an input signal over a number of outputs
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/24Coupling light guides
    • G02B6/42Coupling light guides with opto-electronic elements
    • G02B6/4201Packages, e.g. shape, construction, internal or external details
    • G02B6/4246Bidirectionally operating package structures

Definitions

  • the present invention concerns an MRI-compatible medical device with passive generation of optical sensing signals.
  • Electro- optical and opto-electrical transducers are used to convert between electrical and optical signals.
  • a laser diode located in a main pacemaker enclosure at a proximal end of the photonic catheter is used to convert electrical pulse signals generated by a pulse generator into optical pulses.
  • the optical pulses are carried over an optical conductor situated in the photonic catheter to a secondary housing at the distal end of the photonic catheter, where they are converted by a photo diode array into electrical pulses for cardiac stimulation.
  • a conventional pacemaker there are direct electrical pathways between the power source (typically a lithium battery) and the circuitry responsible for generating stimulation and sensing signals. Since the circuitry has low power requirements, battery life can be prolonged for relatively long time periods.
  • the power source typically a lithium battery
  • the foregoing problem is solved and an advance in the art is provided by a novel system and method for passive optical sense signal generation in a photonic pacemaker or other opto-electric medical device.
  • the system is adapted to operate at the distal end of an implantable photonic catheter having one or more optical conductors for conducting light energy in two directions between electronics at a proximal end of the catheter and electrical stimulation and sensing components at the catheter distal end.
  • the latter may include pacing electrodes, sensing electrodes, partial oxygen sensors, temperature sensors, etc.
  • An optical unit receives a light input delivered from the catheter proximal end by one (or more) of the optical conductors.
  • the optical unit directs a first portion of the light input as a first light output to an opto-electrical converter for conversion into electrical stimulation signals and directs a second portion of light input as a second light output to one or more optical modulators that modulate the second light output under applied electrical signals.
  • An electrical circuit is connected to the device's sensing component(s).
  • the electrical circuit generates electrical sense signals corresponding to one or more sensed physiological conditions and provides the signals to the optical modulator(s). This results in modulation of the second light output into optical sense signals that are transmitted over one or more of the catheter's optical pathways to the catheter proximal end.
  • the optical unit comprises a prismatic optical homogenizer having a first end adapted to receive the light input and a second end having a partially reflective coating thereon.
  • the partially reflective coating allows the portion of the light input to pass as the first light output and reflects the second portion of the light input back to the first end as the second light output.
  • the optical modulators can then be mounted on the first end of the optical homogenizer.
  • the partially reflective coating can be formed as a partially reflective material covering the entire second end. Alternatively, it can be formed as a fully reflective material covering a peripheral portion of the second end while leaving uncovered a central portion of the second end for transmitting the second portion of the light input.
  • the optical modulator can be formed from a crystalline material having electrically controllable optical properties.
  • Exemplary materials include crystal structures selected from the group consisting of lithium niobate, indium phosphide, and gallium arsenide.
  • the electrical circuit is preferably adapted to condition a physiological sense signal generated via interaction with body tissue into the electrical sense signal.
  • the electrical circuit is preferably also adapted to obtain electrical power from the transmitted light output. Additionally, the electrical circuit may be adapted to convert the electrical sense signal form analog to digital form.
  • the present invention further contemplates, respectively, a photonic pacemaker and an opto-electric medical stimulation system having the above-summarized optical sense signal generating functionality therein.
  • Figure 1 is a partial diagrammatic side view showing the distal end of a photonic catheter that incorporates an optical sense signal generation system in accordance with the present invention
  • Figure 2 is a perspective view of an optical assembly forming part of the optical sense signal generation system of Figure 1;
  • Figures 3 and 4 are cross-sectional views taken along line 3-3 in Figure 2 showing alternative partial light reflecting structures of an optical homogenizer constructed in accordance with the present invention;
  • Figure 5 is a functional block diagram of an electronic circuit assembly forming part
  • Figure 6 is a functional block diagram showing the interconnection of electronic and optical circuitry in an opto-electric medical device incorporating a sense signal generation
  • FIG. 7 is a diagrammatic view of an implantable pacemaker in accordance with the present invention.
  • Figure 8 is a diagrammatic view of a wearable pacemaker in accordance with the present invention.
  • Figure 1 illustrates a passive optical sense signal generation system 10 located at the distal end of an implantable photonic catheter 12.
  • the photonic catheter 12 is operatively connected to a photonic pacemaker or other opto-electric medical stimulation/sensing device (not shown in Figure 1).
  • Such devices may include, but are not limited to, optically driven defibrillators, neural stimulators, and other medical equipment designed to perform body tissue stimulation and/or sensing functions using optical transmission signals.
  • the catheter 12 is preferably has a diameter no larger than 5 millimeters, which should be suitable for cardiac implantation.
  • the catheter 12 should be smaller.
  • the catheter 12 has at least one, and preferably several optical conductors (such as optical glass fibers) for conducting light energy in two directions between electronics at a proximal end of the catheter and electrical stimulation and sensing components at the catheter's distal end.
  • the electronics at the catheter proximal end may be implanted within a patient's body or may be external to the body.
  • the catheter distal end comprises optical and opto-electronic components, electronic circuitry and electrodes that provide electrical interfaces to body tissue.
  • optical conductor 14 is adapted to carry optical signals in a downstream direction from the catheter proximal end to the catheter distal end.
  • the optical conductors 16 and 18 are adapted to carry optical signals in an upstream direction from the catheter distal end to the catheter proximal end. All of the optical conductors are encased in a flexible sheath 20 that is made from a material that is biocompatible and non-electrically conductive, such as silicone rubber.
  • the components of the sense signal generation system 10 are contained within a housing 30 that is preferably cylindrical and of the same diameter as the sheath 20.
  • the principal components of the sense signal generation system 10 are an optical unit 32, one or more optical modulators 34 (two are shown), and an electronic circuit assembly 36.
  • the optical unit 32 and the optical modulators 34 are preferably combined with an opto-electrical converter 38 (e.g., a photodiode array) to form an integrated optical detector/modulator assembly 40.
  • the optical detector/modulator assembly 40 provides an interface between the optical conductors 14-18 and the electronic circuit assembly 36. The latter further provides an interface to plural physiologic interaction components designed to interact with implanted body tissue in a medically sigmficant manner by imparting stimulating electrical signals, by sensing physiological activity, or both.
  • a ring electrode 50 and a tip electrode 52 are depicted by way of example. Both of these physiologic electrodes are electrically connected to the electronic circuit assembly 36 via respective electrical leads 54 and 56.
  • the electrodes 50 and 52 provide connections to body tissue in order to support electrical stimulation and monitoring functions.
  • the electrodes 50/52 could be used to deliver pacing, defibrillation, or other stimulation pulses.
  • the electrodes 50/52 could be used for sensing cardiac R waves or other physiological electrical activity.
  • the electrodes 50 and 52 are made from a suitable electrically conductive, biocompatible material, such as platinum or an alloy thereof.
  • the ring electrode 50 is preferably cylindrical in shape while the tip electrode 52 is generally bullet shaped to facilitate tissue implantation. Both electrodes can be formed with hollow cavities that are filled with a biocompatible non-electrically conductive material, such as the material forming the catheter sheath 20. The same material can also be used to form a pair of short cylindrical stub members 58 and 60.
  • the stub member 58 separates and electrically isolates the ring electrode 50 from the housing 30.
  • the stub member 60 separates and electrically isolates the tip electrode 52 from the ring electrode 50.
  • physiologic interaction components could be provided at the distal end of the catheter 12. Such components include partial oxygen sensors, temperature sensors, and other devices.
  • the housing 30 may itself be a physiologic electrode for delivering and/or sensing electrical signals.
  • the housing 30 would then be preferably made from the same material as the electrodes 50 and 52.
  • An electrical lead 62 would comiect the housing 30 to the electronic circuit assembly 36.
  • the various components within the housing 30 should be hermetically sealed to protect the components from body fluids. This can be done in a variety of ways. For example, after the components are situated in the housing 30, the housing interior can be charged with a biocompatible insulative material, such as the material used to form the catheter sheath 30 and the stubs 58 and 60.
  • the housing 30 is not be the only structure that can be used to house the various components of the system. Persons skilled in the art will appreciate that alternative designs could be readily implemented in which the components of the sense signal generation system 10 are situated within the ring electrode 50, or within the tip electrode 52, or possibly distributed across plural housing and/or electrodes.
  • Figures 2, 3 and 4 the design of the optical detector/modulator assembly 40 will now be described. As stated above, the main components of this assembly are the optical unit 32, one or more optical modulators 34, and an opto-electrical converter 38.
  • the optical unit 32 is adapted to receive a light input from the distal end of the optical conductor 14.
  • the optical unit 32 directs a first portion of the light input as a first light output to the opto-electrical converter 38 for conversion into electrical stimulation signals.
  • the optical unit 32 directs a second portion of light input as a second light output to the optical modulators 34, which modulate the second light output under applied electrical signals provided by the electronic circuit 36.
  • the optical unit thus functions in the manner of an optical splitter whose job is to direct one portion of the light input to the opto-electrical converter 38 while directing (e.g., by partial reflection) another portion of the light input to the optical modulators 34.
  • Figure 2 illustrates one possible implementation in which the optical unit 32 is constructed as an optical homogenizer 60.
  • the optical homogenizer 60 has a first end 62 adapted to mount or otherwise functionally interact with the distal end of the optical conductor 14, so as to thereby receive a light input therefrom, and to mount the optical modulators 34.
  • the optical homogenizer 60 has a second end 64 that is associated with a partial light reflecting structure 66, and is also adapted to mount the opto-electrical converter 38.
  • the optical homogenizer 60 is a prismatic optical homogenizer constructed from glass or other suitable material. Such devices are generally known in the optical communications art.
  • the optical homogenizer 60 should be preferably no wider than 1-3 millimeters and no longer than about 3-10 millimeters. Neuro-stimulation applications will typically require smaller dimensions.
  • the optical homogenizer 60 of Figure 2 is a hexagonal prism. Other configurations, including cylinders, could also be used.
  • the design of the optical homogenizer 60 preferably maximizes the energy transfer of the first light output provided to the opto- electrical converter 38.
  • the partial light reflecting structure 66 can be implemented in a variety of ways, but is preferably formed as a coating on the back face of the optical homogenizer's second end 64.
  • a partially reflective coating material 68 could be applied so as to cover substantially all of the second end 64. All areas of the coating 68 would pass the first light output to the opto-electrical converter while reflecting the second light output to the optical modulators 34.
  • a fully reflective coating material 70 could be applied to only a peripheral portion of the second end 64 so as to leave uncovered a central portion 72 of the second end.
  • the open central portion 72 would pass a central portion of the light input as the first light output to the opto-electrical converter 38.
  • the peripheral area of the second end 64 having the fully reflective material 70 applied thereto would then reflect a peripheral portion of the light input as the second light output to the optical modulators 34.
  • coating materials 68 and 70 can be applied to the second end 64 using conventional techniques.
  • the optical modulators 34 are mounted on the front end 62 of the optical homogenizer 60. Each optical modulator 34 also connects to, or otherwise functionally interacts with, a respective one of the optical conductors 16 and 18. Each optical modulator 34 further has a pair of electrical leads 80 and 82 respectively connected to opposing faces thereof. As described in more detail below, the electrical lead pairs 80/82 are connected to a modulating element of the electronic circuit 36, so that the electronic circuit is able to modulate light passing through the optical modulators 34. In particular, the electrical signals from the electronic circuit 36 serve to modulate the intensity of the light passed through the optical modulators 34 in proportion to the applied electrical signals. With this arrangement, the modulators 34 are positioned to receive the second light output provided by the partial light reflecting structure 66, and to feed the second light output with an applied modulation signal into the optical conductors 16 and 18 for transport to the proximal end of the catheter 12.
  • the optical modulators can be formed in conventional fashion from a crystalline material having electrically controllable optical properties.
  • Exemplary materials include crystal structures selected from the group consisting of lithium niobate, indium phosphide, and gallium arsenide, as is well known in the optical communications art.
  • the physics of a high voltage version of a lithium niobate optical modulator are discussed in A.M. Prokhorov et al., "Physics and Chemistry of Crystalline Lithium Niobate, (1990).
  • a lithium niobate modulator is described that is five millimeters in length (between the faces that mount the electrical comiections) and two millimeters in width (in the direction of the light transmitted through the optical modulator).
  • This prior art optical modulator uses a control voltage of up to 5000 volts.
  • optical modulators 34 For the optical modulators 34 described herein, a much lower control voltage is used. Thus, a much thinner optical modulator element, perhaps only a millimeter or less on each side, will be used to permit use of a control voltage of a few volts. Persons skilled in the art will recognize that other light modulator materials, such as indium phosphide or gallium arsenide, could be used with corresponding different control voltages.
  • the opto-electrical converter 38 is mounted at the second end 64 of the optical homogenizer 60.
  • the purpose of the opto-electrical converter 38 is to convert the incident light energy into electrical energy for physiological stimulation and to power the co- located electronic circuit 36.
  • the opto-electrical transducer 38 may be constructed in a variety of ways, but is preferably implemented as an array of six series-connected photo diodes to develop the required photovoltaic output.
  • the electrical output of the opto-electric converter 38 is connected to the physiologic electrodes 50, 52, and 60 of Figure 1 by way of the electronic circuit 36. Electrical leads 74 and 76 connect the opto-electrical converter 38 to the electrical circuit 36.
  • the operation of the optical detector/modulator assembly 40 depicted in Figure 2 may be summarized as follows: Light energy from a source at the proximal end of the catheter 12 enters the first end 62 of the optical homogenizer 60 from the optical conductor 14 and is dispersed within the optical homogenizer.
  • the optical homogenizer 60 is constructed in such a manner (by way of the partial light reflecting structure 66) as to transmit the bulk of the light input to the opto-electrical converter 38 while reflecting a small amount (e.g., less than 10%) of the incident light energy from its second end 64 back to its first end 62, where the optical modulators 34 are located.
  • the reflected light energy will be passed through the optical modulators 34, modulated by the electronic circuit 36, and coupled into the optical conductors 16 and 18 to provide optical sense signals back to the electronics at the proximal end of the catheter 12.
  • the electronic circuit 36 of Figure 1 performs several functions, including (1) providing electrical stimulation pulses to all electrodes performing a medical stimulation function, (2) amplifying or otherwise conditioning all physiological inputs received from sensing electrodes and other sensing components into electrical sense signals, and (3) optionally converting the electrical sense signals from analog to digital form for modulating the optical modulators 34.
  • the electronic circuit 36 receives electrical power in the form of electrical pulses from the opto-electrical converter 38, by way of the electrical leads 74 and 76.
  • a typical pulse would last about 1-10 milliseconds and develop a voltage potential of about 3-9 volts at a current level of about 4 milliamperes. This would produce a pulse power level of about 16 milliwatts, which would be sufficient for a medical stimulation function such as cardiac pacing.
  • the pulses are delivered to an energy storage and conversion unit 80 whose function is to divert a portion of the electrical energy as power for other components of the electronic circuit 36, while coupling the bulk of the electrical energy to the stimulation electrodes via the electrical pathways 82 and 84.
  • the energy storage and conversion unit 80 can be implemented using a conventional charge pump circuit that rectifies and stores the input electrical pulses using one or more capacitors.
  • the diverted electrical power is provided to electrical power bus elements 85.
  • the electronic circuit 36 also includes an R wave amplifier 86 that is adapted to receive physiological sense signals from sensing electrode implanted in a patient's heart.
  • the R wave amplifier 86 connects to the sensing electrodes via electrical pathways 82 and 84. It receives primary power from the power bus 85.
  • the sensing electrodes could be the electrodes 50 and 52 of Figure 1, in which case the electrical pathways 83 and 84 would respectively comprise the electrical leads 54 and 56.
  • the R wave amplifier 86 converts the heart's R wave pulse signals into electrical sense signals that are of sufficient power to modulate the optical modulators 34.
  • the R wave amplifier can be implemented using any suitable low power amplification circuit designed for operation in the sub-milliwatt range.
  • FIG. 5 shows one such signal conditioning unit 88 receiving physiological sense signals via a pair of electrical pathways 90 and 92.
  • the signal conditioning unit 88 could be an amplifier or any other circuit adapted to scale a physiological sense signal generated via interaction with body tissue to an electrical sense signal of sufficient power to modulate the optical modulators 34. It could be connected to a desired sensor type, including partial oxygen sensors, temperature sensors, etc. Primary power is provided to the signal conditioning unit 88 via the power bus 86.
  • the electronic circuit 36 may additionally include an analog-to-digital (A/D) conversion circuit 94 for converting the electrical sense signals generated by the R wave amplifier 86 and the signal conditioning circuit 88 from analog to digital form.
  • A/D analog-to-digital
  • the A/D conversion circuit 94 receives power over the power bus 86. It receives analog sense signal inputs from R wave amplifier 86 and the signal conditioning unit 88 over respective electrical pathways 96 and 98. The digital outputs of the A/D conversion circuit 94 deliver digital outputs to the optical modulators 34 via the electrical pathways 80 and 82. The digital outputs provided by the A/D conversion circuit 94 are serial outputs.
  • a conventional voltage-to-frequency (N/F) counter circuit may be used to implement the A/D conversion circuit 94. As is well known, such circuits produce a pulsitile output at a frequency that is based on the voltage level of the input analog signal.
  • Figure 6 shows exemplary electronic circuit and optical components that might be found at the proximal end of the catheter 12.
  • a prime energy source 100 such as a battery, provides prime power for the circuitry at the proximal end of the opto-electric medical device being implemented.
  • the proximal end also includes a pulse generator circuit 102 to control and drive an electro-optical converter, such as a laser diode 104, which converts the applied electrical energy to light energy.
  • the laser diode 104 will preferably be operated in a pulsed mode to minimize energy dissipation and to control physiological stimulation when required.
  • the laser diode output energy is coupled to the optical conductor 14 and conducted to the distal end of the catheter 12.
  • the light energy delivered by the optical conductor 14 is applied to the optical homogenizer 60.
  • the optical homogenizer 60 couples the bulk of the incident light input into the opto-electrical converter 38.
  • the light is converted to electrical energy to power the electronic circuit 36 and provide physiological stimulation, as previously stated.
  • the remainder of the light input is reflected by the partial light reflecting structure 66 back to the optical modulators 34.
  • Electrical input signals from the electrodes and sensors at the distal end of the catheter 12 are amplified or conditioned and converted to digital pulse signals that modulate the optical modulators 34. This varies the light intensity passed through to the optical conductors 16 and 18 in proportion to the monitored physiological parameters, thereby providing encoded optical sense signals.
  • the modulated light energy carried on the optical conductors 16 and 18 from the distal end of the catheter is coupled to opto-electrical converters 106 and 108 to convert the optical sense signals to electrical sense signals.
  • the electrical sense signals are provided to an electronic circuit assembly 110 comprising a digital-to-analog (D/A) converter and a signal processing circuit.
  • the D/A converter converts the digital electrical sense signals to analog form and the signal processing circuit interprets the converted analog signals to recover the physiological parameters. The latter can then be used for any desired purpose, such as to affect the operation of the pulse generator 102 to provide a desired therapeutic effect.
  • Figures 7 and 8 two exemplary embodiments of the present invention are shown in which the optical sense signal generation system 10 is respectively incorporated in an implantable photonic pacemaker and a wearable photonic pacemaker.
  • Figures 7 and 8 further illustrate the use of two electrodes in which the ring electrode is used to house the system 10.
  • an implantable photonic pacemaker 120 includes an implantable housing 122 that preferably contains the proximal end circuit components shown in Figure 6.
  • the housing 122 mounts the proximal end 124 of a photonic catheter 126 that can be constructed in the same way as the catheter 12 of Figure 1.
  • a tip/ring electrode termination pair 130 comprising a ring electrode 132 and a tip electrode 134 separated by a short insulative stub 136.
  • the ring electrode 132 forms a housing that contains the various electrical and optical components that provide the optical sense signal generation system 10.
  • a wearable pacemaker 220 includes a wearable housing 222 that preferably contains the proximal end circuit components shown in Figure 6.
  • the housing 222 mounts the proximal end 224 of a photonic catheter 226 that can be constructed in the same way as the catheter 12 of Figure 1.
  • a tip/ring electrode termination pair 230 comprising a ring electrode 232 and a tip electrode 234 separated by a short insulative stub 236.
  • the ring electrode 232 forms a housing that contains the various electrical and optical components that provide the optical sense signal generation system 10.
  • an optical diverter at the distal end of a photonic catheter that diverts a small portion of light energy delivered from the proximal end of the catheter back up one or more optical conductors.
  • One or more optical modulators are provided in the path of the diverted light.
  • the optical modulators modulate the intensity of the diverted light in accordance with one or more physiological variables such as, for example, R wave electrocardiographic activity. While various embodiments of the present invention have been shown and described, it should be apparent that many variations and alternative embodiments could be implemented in accordance with the present invention. It is understood, therefore, that the present invention is not to be in any way limited except in accordance with the spirit of the appended claims and their equivalents.

Abstract

An optical device is implemented in a medical device having a photonic catheter containing optical conductors conducting light energy in two directions between electronics at a catheter proximal end and electrical stimulation and sensing components at a catheter distal end. The optical device includes an optical unit (60 of Figure 5), which receives light delivered from the catheter proximal end and transmits a first portion of the light to an opto­electrical converter (38 of Figure 5) while diverting a second portion of the light to optical modulators (34 of Figure 5). The transmitted light is converted to electrical signals by the opto-electrical converter (38 of Figure 5). The diverted light is modulated by one or more optical modulators (34 of Figure 5) wherein the modulation is based upon electrical signals received from an optical sense signal generator (36 of Figure 5). The optical sense signal generator (36 of Figure 5) generates electrical sense signals corresponding to one or more sensed physiological conditions such that the electrical sense signals control the modulation of the optical modulator(s) (34 of Figure 5). This results in modulation of the diverted light output into optical sense signals that are transmitted to the catheter proximal end.

Description

MRI-COMPATIBLE MEDICAL DEVICE WITH PASSIVE GENERATION OF OPTICAL SENSING SIGNALS
FIELD OF THE PRESENT INVENTION The present invention relates to photonic pacemakers designed for compatibility with
MRI diagnostic equipment, and to other opto-electric medical stimulation and sensing equipment. More particularly, the present invention concerns an MRI-compatible medical device with passive generation of optical sensing signals.
BACKGROUND OF THE PRESENT INVENTION
MRI compatible pacemakers for both implantable and wearable use have featured photonic catheters carrying optical signals in lieu of metallic leads carrying electrical signals in order to avoid the dangers associated with MRI-generated electromagnetic fields. Electro- optical and opto-electrical transducers are used to convert between electrical and optical signals. In particular, a laser diode located in a main pacemaker enclosure at a proximal end of the photonic catheter is used to convert electrical pulse signals generated by a pulse generator into optical pulses. The optical pulses are carried over an optical conductor situated in the photonic catheter to a secondary housing at the distal end of the photonic catheter, where they are converted by a photo diode array into electrical pulses for cardiac stimulation.
Despite the advances in pacemaker MRI compatibility offered by the devices featuring photonic catheters carrying optical signals, there remains a problem of how to provide physiological sensing capability in such devices.
In a conventional pacemaker, there are direct electrical pathways between the power source (typically a lithium battery) and the circuitry responsible for generating stimulation and sensing signals. Since the circuitry has low power requirements, battery life can be prolonged for relatively long time periods.
With a photonic pacemaker, the power requirements are greater due to the high current demands of the laser diodes used for optical signal generation, and the inefficiencies associated with opto-electrical and electro-optical conversion. Sensing signals are especially problematic.
Most devices used to sense physiological conditions rely on electrical signals. These include "R" wave sensors for sensing electrical activity in the heart, partial oxygen (ρO ) sensors, temperature sensors, etc. Such electrical signals are very low in power (e.g., less than one milliwatt) and cannot be directly used to drive conventional electro-optical transducers, such as laser diodes or light emitting diodes. Instead, such electrical signals need to be amplified or otherwise conditioned in order to boost their strength to a point where such electrical signals can be converted into optical form. Only then can the sensing signals be transported over the photonic catheter to upstream sensing circuitry. It will thus be appreciated that a source of electrical power is required at the distal end of the photonic catheter. This poses a non-trivial design problem in the photonic medical equipment art.
SUMMARY OF THE PRESENT INVENTION The foregoing problem is solved and an advance in the art is provided by a novel system and method for passive optical sense signal generation in a photonic pacemaker or other opto-electric medical device. The system is adapted to operate at the distal end of an implantable photonic catheter having one or more optical conductors for conducting light energy in two directions between electronics at a proximal end of the catheter and electrical stimulation and sensing components at the catheter distal end. The latter may include pacing electrodes, sensing electrodes, partial oxygen sensors, temperature sensors, etc.
An optical unit receives a light input delivered from the catheter proximal end by one (or more) of the optical conductors. The optical unit directs a first portion of the light input as a first light output to an opto-electrical converter for conversion into electrical stimulation signals and directs a second portion of light input as a second light output to one or more optical modulators that modulate the second light output under applied electrical signals. An electrical circuit is connected to the device's sensing component(s). The electrical circuit generates electrical sense signals corresponding to one or more sensed physiological conditions and provides the signals to the optical modulator(s). This results in modulation of the second light output into optical sense signals that are transmitted over one or more of the catheter's optical pathways to the catheter proximal end. In preferred implementations of the present invention, the optical unit comprises a prismatic optical homogenizer having a first end adapted to receive the light input and a second end having a partially reflective coating thereon. The partially reflective coating allows the portion of the light input to pass as the first light output and reflects the second portion of the light input back to the first end as the second light output. The optical modulators can then be mounted on the first end of the optical homogenizer. The partially reflective coating can be formed as a partially reflective material covering the entire second end. Alternatively, it can be formed as a fully reflective material covering a peripheral portion of the second end while leaving uncovered a central portion of the second end for transmitting the second portion of the light input. The optical modulator can be formed from a crystalline material having electrically controllable optical properties. Exemplary materials include crystal structures selected from the group consisting of lithium niobate, indium phosphide, and gallium arsenide. The electrical circuit is preferably adapted to condition a physiological sense signal generated via interaction with body tissue into the electrical sense signal. The electrical circuit is preferably also adapted to obtain electrical power from the transmitted light output. Additionally, the electrical circuit may be adapted to convert the electrical sense signal form analog to digital form.
The present invention further contemplates, respectively, a photonic pacemaker and an opto-electric medical stimulation system having the above-summarized optical sense signal generating functionality therein.
BRIEF DESCRIPTION OF THE DRAWINGS
The foregoing and other features and advantages of the present invention will be apparent from the following more particular description of preferred embodiments of the present invention, as illustrated in the accompanying Drawings in which: Figure 1 is a partial diagrammatic side view showing the distal end of a photonic catheter that incorporates an optical sense signal generation system in accordance with the present invention;
Figure 2 is a perspective view of an optical assembly forming part of the optical sense signal generation system of Figure 1; Figures 3 and 4 are cross-sectional views taken along line 3-3 in Figure 2 showing alternative partial light reflecting structures of an optical homogenizer constructed in accordance with the present invention;
Figure 5 is a functional block diagram of an electronic circuit assembly forming part
of the optical sense signal generation system of Figure 1;
Figure 6 is a functional block diagram showing the interconnection of electronic and optical circuitry in an opto-electric medical device incorporating a sense signal generation
system in accordance with the present invention;
Figure 7 is a diagrammatic view of an implantable pacemaker in accordance with the present invention; and
Figure 8 is a diagrammatic view of a wearable pacemaker in accordance with the present invention.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS Turning now to the Drawings wherein like reference numerals signify like elements in all of the several views, Figure 1 illustrates a passive optical sense signal generation system 10 located at the distal end of an implantable photonic catheter 12. As will be described in more detail below, the photonic catheter 12 is operatively connected to a photonic pacemaker or other opto-electric medical stimulation/sensing device (not shown in Figure 1). Such devices may include, but are not limited to, optically driven defibrillators, neural stimulators, and other medical equipment designed to perform body tissue stimulation and/or sensing functions using optical transmission signals. The catheter 12 is preferably has a diameter no larger than 5 millimeters, which should be suitable for cardiac implantation. For neuro-stimulation applications, the catheter 12 should be smaller. The catheter 12 has at least one, and preferably several optical conductors (such as optical glass fibers) for conducting light energy in two directions between electronics at a proximal end of the catheter and electrical stimulation and sensing components at the catheter's distal end. The electronics at the catheter proximal end may be implanted within a patient's body or may be external to the body. The catheter distal end comprises optical and opto-electronic components, electronic circuitry and electrodes that provide electrical interfaces to body tissue.
Three optical conductors 14, 16, and 18 are shown by way of example in Figure 1. The optical conductor 14 is adapted to carry optical signals in a downstream direction from the catheter proximal end to the catheter distal end. The optical conductors 16 and 18 are adapted to carry optical signals in an upstream direction from the catheter distal end to the catheter proximal end. All of the optical conductors are encased in a flexible sheath 20 that is made from a material that is biocompatible and non-electrically conductive, such as silicone rubber.
The components of the sense signal generation system 10 are contained within a housing 30 that is preferably cylindrical and of the same diameter as the sheath 20. The principal components of the sense signal generation system 10 are an optical unit 32, one or more optical modulators 34 (two are shown), and an electronic circuit assembly 36. The optical unit 32 and the optical modulators 34 are preferably combined with an opto-electrical converter 38 (e.g., a photodiode array) to form an integrated optical detector/modulator assembly 40. The optical detector/modulator assembly 40 provides an interface between the optical conductors 14-18 and the electronic circuit assembly 36. The latter further provides an interface to plural physiologic interaction components designed to interact with implanted body tissue in a medically sigmficant manner by imparting stimulating electrical signals, by sensing physiological activity, or both.
A ring electrode 50 and a tip electrode 52 are depicted by way of example. Both of these physiologic electrodes are electrically connected to the electronic circuit assembly 36 via respective electrical leads 54 and 56. The electrodes 50 and 52 provide connections to body tissue in order to support electrical stimulation and monitoring functions. For example, the electrodes 50/52 could be used to deliver pacing, defibrillation, or other stimulation pulses. In addition, or in the alternative, the electrodes 50/52 could be used for sensing cardiac R waves or other physiological electrical activity.
The electrodes 50 and 52 are made from a suitable electrically conductive, biocompatible material, such as platinum or an alloy thereof. The ring electrode 50 is preferably cylindrical in shape while the tip electrode 52 is generally bullet shaped to facilitate tissue implantation. Both electrodes can be formed with hollow cavities that are filled with a biocompatible non-electrically conductive material, such as the material forming the catheter sheath 20. The same material can also be used to form a pair of short cylindrical stub members 58 and 60. The stub member 58 separates and electrically isolates the ring electrode 50 from the housing 30. The stub member 60 separates and electrically isolates the tip electrode 52 from the ring electrode 50.
Although not shown, it will be appreciated that other physiologic interaction components could be provided at the distal end of the catheter 12. Such components include partial oxygen sensors, temperature sensors, and other devices. Note that the housing 30 may itself be a physiologic electrode for delivering and/or sensing electrical signals. The housing 30 would then be preferably made from the same material as the electrodes 50 and 52. An electrical lead 62 would comiect the housing 30 to the electronic circuit assembly 36.
Note that the various components within the housing 30 should be hermetically sealed to protect the components from body fluids. This can be done in a variety of ways. For example, after the components are situated in the housing 30, the housing interior can be charged with a biocompatible insulative material, such as the material used to form the catheter sheath 30 and the stubs 58 and 60.
Before turning to the construction details of the sense signal generation system 10, it should be further mentioned that the housing 30 is not be the only structure that can be used to house the various components of the system. Persons skilled in the art will appreciate that alternative designs could be readily implemented in which the components of the sense signal generation system 10 are situated within the ring electrode 50, or within the tip electrode 52, or possibly distributed across plural housing and/or electrodes. Turning now to Figures 2, 3 and 4, the design of the optical detector/modulator assembly 40 will now be described. As stated above, the main components of this assembly are the optical unit 32, one or more optical modulators 34, and an opto-electrical converter 38. The optical unit 32 is adapted to receive a light input from the distal end of the optical conductor 14. The optical unit 32 directs a first portion of the light input as a first light output to the opto-electrical converter 38 for conversion into electrical stimulation signals. The optical unit 32 directs a second portion of light input as a second light output to the optical modulators 34, which modulate the second light output under applied electrical signals provided by the electronic circuit 36. The optical unit thus functions in the manner of an optical splitter whose job is to direct one portion of the light input to the opto-electrical converter 38 while directing (e.g., by partial reflection) another portion of the light input to the optical modulators 34.
The foregoing functionality of the optical unit can be provided in a variety of ways, using a variety of optical unit configurations. Figure 2 illustrates one possible implementation in which the optical unit 32 is constructed as an optical homogenizer 60. The optical homogenizer 60 has a first end 62 adapted to mount or otherwise functionally interact with the distal end of the optical conductor 14, so as to thereby receive a light input therefrom, and to mount the optical modulators 34. The optical homogenizer 60 has a second end 64 that is associated with a partial light reflecting structure 66, and is also adapted to mount the opto-electrical converter 38. hi preferred implementations of the present invention, the optical homogenizer 60 is a prismatic optical homogenizer constructed from glass or other suitable material. Such devices are generally known in the optical communications art. However, a smaller scale device is required for implantable medical use. For example, to be fully implantable for cardiac applications, the optical homogenizer 60 should be preferably no wider than 1-3 millimeters and no longer than about 3-10 millimeters. Neuro-stimulation applications will typically require smaller dimensions. The optical homogenizer 60 of Figure 2 is a hexagonal prism. Other configurations, including cylinders, could also be used.
The design of the optical homogenizer 60, including the partial reflector structure 66, preferably maximizes the energy transfer of the first light output provided to the opto- electrical converter 38. To that end, the partial light reflecting structure 66 can be implemented in a variety of ways, but is preferably formed as a coating on the back face of the optical homogenizer's second end 64.
Different coating configurations and materials can be used. For example, as shown in
Figure 3, a partially reflective coating material 68 could be applied so as to cover substantially all of the second end 64. All areas of the coating 68 would pass the first light output to the opto-electrical converter while reflecting the second light output to the optical modulators 34.
Alternatively, as shown in Figure 4, a fully reflective coating material 70 could be applied to only a peripheral portion of the second end 64 so as to leave uncovered a central portion 72 of the second end. The open central portion 72 would pass a central portion of the light input as the first light output to the opto-electrical converter 38. The peripheral area of the second end 64 having the fully reflective material 70 applied thereto would then reflect a peripheral portion of the light input as the second light output to the optical modulators 34.
Note that the coating materials 68 and 70 can be applied to the second end 64 using conventional techniques.
The optical modulators 34 are mounted on the front end 62 of the optical homogenizer 60. Each optical modulator 34 also connects to, or otherwise functionally interacts with, a respective one of the optical conductors 16 and 18. Each optical modulator 34 further has a pair of electrical leads 80 and 82 respectively connected to opposing faces thereof. As described in more detail below, the electrical lead pairs 80/82 are connected to a modulating element of the electronic circuit 36, so that the electronic circuit is able to modulate light passing through the optical modulators 34. In particular, the electrical signals from the electronic circuit 36 serve to modulate the intensity of the light passed through the optical modulators 34 in proportion to the applied electrical signals. With this arrangement, the modulators 34 are positioned to receive the second light output provided by the partial light reflecting structure 66, and to feed the second light output with an applied modulation signal into the optical conductors 16 and 18 for transport to the proximal end of the catheter 12.
The optical modulators can be formed in conventional fashion from a crystalline material having electrically controllable optical properties. Exemplary materials include crystal structures selected from the group consisting of lithium niobate, indium phosphide, and gallium arsenide, as is well known in the optical communications art. The physics of a high voltage version of a lithium niobate optical modulator are discussed in A.M. Prokhorov et al., "Physics and Chemistry of Crystalline Lithium Niobate, (1990). In addition, a lithium niobate modulator is described that is five millimeters in length (between the faces that mount the electrical comiections) and two millimeters in width (in the direction of the light transmitted through the optical modulator). This prior art optical modulator uses a control voltage of up to 5000 volts.
For the optical modulators 34 described herein, a much lower control voltage is used. Thus, a much thinner optical modulator element, perhaps only a millimeter or less on each side, will be used to permit use of a control voltage of a few volts. Persons skilled in the art will recognize that other light modulator materials, such as indium phosphide or gallium arsenide, could be used with corresponding different control voltages.
As stated above, the opto-electrical converter 38 is mounted at the second end 64 of the optical homogenizer 60. The purpose of the opto-electrical converter 38 is to convert the incident light energy into electrical energy for physiological stimulation and to power the co- located electronic circuit 36. The opto-electrical transducer 38 may be constructed in a variety of ways, but is preferably implemented as an array of six series-connected photo diodes to develop the required photovoltaic output. The electrical output of the opto-electric converter 38 is connected to the physiologic electrodes 50, 52, and 60 of Figure 1 by way of the electronic circuit 36. Electrical leads 74 and 76 connect the opto-electrical converter 38 to the electrical circuit 36.
The operation of the optical detector/modulator assembly 40 depicted in Figure 2 may be summarized as follows: Light energy from a source at the proximal end of the catheter 12 enters the first end 62 of the optical homogenizer 60 from the optical conductor 14 and is dispersed within the optical homogenizer. The optical homogenizer 60 is constructed in such a manner (by way of the partial light reflecting structure 66) as to transmit the bulk of the light input to the opto-electrical converter 38 while reflecting a small amount (e.g., less than 10%) of the incident light energy from its second end 64 back to its first end 62, where the optical modulators 34 are located. The reflected light energy will be passed through the optical modulators 34, modulated by the electronic circuit 36, and coupled into the optical conductors 16 and 18 to provide optical sense signals back to the electronics at the proximal end of the catheter 12. Turning now to Figure 5, the electronic circuit 36 of Figure 1 is shown in more detail. This circuit performs several functions, including (1) providing electrical stimulation pulses to all electrodes performing a medical stimulation function, (2) amplifying or otherwise conditioning all physiological inputs received from sensing electrodes and other sensing components into electrical sense signals, and (3) optionally converting the electrical sense signals from analog to digital form for modulating the optical modulators 34. The electronic circuit 36 receives electrical power in the form of electrical pulses from the opto-electrical converter 38, by way of the electrical leads 74 and 76.
A typical pulse would last about 1-10 milliseconds and develop a voltage potential of about 3-9 volts at a current level of about 4 milliamperes. This would produce a pulse power level of about 16 milliwatts, which would be sufficient for a medical stimulation function such as cardiac pacing. The pulses are delivered to an energy storage and conversion unit 80 whose function is to divert a portion of the electrical energy as power for other components of the electronic circuit 36, while coupling the bulk of the electrical energy to the stimulation electrodes via the electrical pathways 82 and 84. The energy storage and conversion unit 80 can be implemented using a conventional charge pump circuit that rectifies and stores the input electrical pulses using one or more capacitors. The diverted electrical power is provided to electrical power bus elements 85.
The electronic circuit 36 also includes an R wave amplifier 86 that is adapted to receive physiological sense signals from sensing electrode implanted in a patient's heart. The R wave amplifier 86 connects to the sensing electrodes via electrical pathways 82 and 84. It receives primary power from the power bus 85. Note that the sensing electrodes could be the electrodes 50 and 52 of Figure 1, in which case the electrical pathways 83 and 84 would respectively comprise the electrical leads 54 and 56. The R wave amplifier 86 converts the heart's R wave pulse signals into electrical sense signals that are of sufficient power to modulate the optical modulators 34. The R wave amplifier can be implemented using any suitable low power amplification circuit designed for operation in the sub-milliwatt range.
If additional sensing functions are to be performed, other signal conditioning units may be provided and connected to accept inputs from other sensors. Figure 5 shows one such signal conditioning unit 88 receiving physiological sense signals via a pair of electrical pathways 90 and 92. The signal conditioning unit 88 could be an amplifier or any other circuit adapted to scale a physiological sense signal generated via interaction with body tissue to an electrical sense signal of sufficient power to modulate the optical modulators 34. It could be connected to a desired sensor type, including partial oxygen sensors, temperature sensors, etc. Primary power is provided to the signal conditioning unit 88 via the power bus 86. The electronic circuit 36 may additionally include an analog-to-digital (A/D) conversion circuit 94 for converting the electrical sense signals generated by the R wave amplifier 86 and the signal conditioning circuit 88 from analog to digital form. The A/D conversion circuit 94 receives power over the power bus 86. It receives analog sense signal inputs from R wave amplifier 86 and the signal conditioning unit 88 over respective electrical pathways 96 and 98. The digital outputs of the A/D conversion circuit 94 deliver digital outputs to the optical modulators 34 via the electrical pathways 80 and 82. The digital outputs provided by the A/D conversion circuit 94 are serial outputs. A conventional voltage-to-frequency (N/F) counter circuit may be used to implement the A/D conversion circuit 94. As is well known, such circuits produce a pulsitile output at a frequency that is based on the voltage level of the input analog signal.
Turning now to Figure 6, the components of the optical sense signal generator 10 are shown in diagrammatic form at the distal end of the catheter 12. Figure 6 also shows exemplary electronic circuit and optical components that might be found at the proximal end of the catheter 12. At the proximal end of the catheter 12, a prime energy source 100, such as a battery, provides prime power for the circuitry at the proximal end of the opto-electric medical device being implemented. The proximal end also includes a pulse generator circuit 102 to control and drive an electro-optical converter, such as a laser diode 104, which converts the applied electrical energy to light energy. The laser diode 104 will preferably be operated in a pulsed mode to minimize energy dissipation and to control physiological stimulation when required. The laser diode output energy is coupled to the optical conductor 14 and conducted to the distal end of the catheter 12.
At the distal end of the catheter 12, the light energy delivered by the optical conductor 14 is applied to the optical homogenizer 60. The optical homogenizer 60 couples the bulk of the incident light input into the opto-electrical converter 38. Here, the light is converted to electrical energy to power the electronic circuit 36 and provide physiological stimulation, as previously stated. The remainder of the light input is reflected by the partial light reflecting structure 66 back to the optical modulators 34. Electrical input signals from the electrodes and sensors at the distal end of the catheter 12 are amplified or conditioned and converted to digital pulse signals that modulate the optical modulators 34. This varies the light intensity passed through to the optical conductors 16 and 18 in proportion to the monitored physiological parameters, thereby providing encoded optical sense signals. Back at the proximal end of the catheter 12, the modulated light energy carried on the optical conductors 16 and 18 from the distal end of the catheter is coupled to opto-electrical converters 106 and 108 to convert the optical sense signals to electrical sense signals. The electrical sense signals are provided to an electronic circuit assembly 110 comprising a digital-to-analog (D/A) converter and a signal processing circuit. The D/A converter converts the digital electrical sense signals to analog form and the signal processing circuit interprets the converted analog signals to recover the physiological parameters. The latter can then be used for any desired purpose, such as to affect the operation of the pulse generator 102 to provide a desired therapeutic effect.
Turning now to Figures 7 and 8, two exemplary embodiments of the present invention are shown in which the optical sense signal generation system 10 is respectively incorporated in an implantable photonic pacemaker and a wearable photonic pacemaker. Figures 7 and 8 further illustrate the use of two electrodes in which the ring electrode is used to house the system 10.
In Figure 7, an implantable photonic pacemaker 120 includes an implantable housing 122 that preferably contains the proximal end circuit components shown in Figure 6. The housing 122 mounts the proximal end 124 of a photonic catheter 126 that can be constructed in the same way as the catheter 12 of Figure 1. At the distal end 128 of the catheter 126 is a tip/ring electrode termination pair 130 comprising a ring electrode 132 and a tip electrode 134 separated by a short insulative stub 136. The ring electrode 132 forms a housing that contains the various electrical and optical components that provide the optical sense signal generation system 10.
In Figure 8, a wearable pacemaker 220 includes a wearable housing 222 that preferably contains the proximal end circuit components shown in Figure 6. The housing 222 mounts the proximal end 224 of a photonic catheter 226 that can be constructed in the same way as the catheter 12 of Figure 1. At the distal end 228 of the catheter 226 is a tip/ring electrode termination pair 230 comprising a ring electrode 232 and a tip electrode 234 separated by a short insulative stub 236. The ring electrode 232 forms a housing that contains the various electrical and optical components that provide the optical sense signal generation system 10.
Accordingly, a system and method for optical sense signal generation been disclosed. As described in detail above, we teach an optical diverter at the distal end of a photonic catheter that diverts a small portion of light energy delivered from the proximal end of the catheter back up one or more optical conductors. One or more optical modulators are provided in the path of the diverted light. The optical modulators modulate the intensity of the diverted light in accordance with one or more physiological variables such as, for example, R wave electrocardiographic activity. While various embodiments of the present invention have been shown and described, it should be apparent that many variations and alternative embodiments could be implemented in accordance with the present invention. It is understood, therefore, that the present invention is not to be in any way limited except in accordance with the spirit of the appended claims and their equivalents.

Claims

I Claim:
1. An optical sense signal generator for photonic pacemakers and other opto- electric medical stimulation equipment and adapted to operate at the distal end of an implantable photonic catheter having one or more optical conductors for conducting light energy in two directions between electronics at a proximal end of the catheter and electrical stimulation and sensing components at the catheter distal end, said optical sense signal generator comprising: an optical unit adapted to receive a light input delivered from said catheter proximal end by one of said optical conductors and to transmit a first portion of said light input as a transmitted light output to an opto-electrical converter for conversion into electrical stimulation signals while diverting a second portion of said light input as a diverted light output; an optical modulator positioned to receive said diverted light output and adapted to modulate said diverted light output under an applied electrical signal; an electrical circuit in said sense signal generator, said electrical circuit being connected to an electrical sensing component at said catheter distal end and adapted to generate an electrical sense signal corresponding to a physiological condition to be sensed by said sensing component; and said electrical circuit being connected to provide said electrical sense signal to said optical modulator in order to modulate said diverted light output into a sensing optical signal.
2. An optical sense signal generator in accordance with Claim 1, wherein said optical unit comprises an optical homogenizer.
3. An optical sense signal generator in accordance with Claim 1, wherein said optical unit comprises a prismatic optical homogenizer having a first end adapted to receive said light input and a second end having a partially reflective coating thereon for reflecting said second portion of said light input to said first end.
4. An optical sense signal generator in accordance with Claim 3, wherein said partially reflective coating comprises a partially reflective material covering all of said second end.
5. An optical sense signal generator in accordance with Claim 1, wherein said partially reflective coating comprises a fully reflective material covering a peripheral portion of said second end while leaving uncovered a central portion of said second end for transmitting said second portion of said light input.
6. An optical sense signal generator in accordance with Claim 1, wherein said optical modulator comprises a crystalline material having electrically controllable optical properties.
7. An optical sense signal generator in accordance with Claim 6, wherein said crystalline material is selected from the group consisting of lithium niobate, indium phosphide and gallium arsenide.
8. An optical sense signal generator in accordance with Claim 1, wherein said electrical circuit comprises means for conditioning a physiological sense signal generated via interaction of said sensing component with body tissue into said electrical sense signal.
9. An optical sense signal generator in accordance with Claim 1, wherein said electrical circuit comprises means for obtaining electrical power from said transmitted light output.
10. An optical sense signal generator in accordance with Claim 1, wherein said electrical circuit comprises means for converting said electrical sense signal from analog to digital form.
11. A photonic pacemaker having a photonic catheter containing one or more optical conductors for conducting light energy in two directions between electronics at a proximal end of said catheter and electrical stimulation and sensing components at a distal end of said catheter, comprising: an optical sense signal generator located at said catheter distal end; an optical unit in said sense signal generator adapted to receive a light input delivered from said catheter proximal end by one of said optical conductors and to transmit a first portion of said light input as a transmitted light output to an opto-electrical converter for conversion into electrical stimulation signals while diverting a second portion of said light input as a diverted light output; an optical modulator in said sense signal generator positioned to receive said diverted light output and adapted to modulate said diverted light output under an applied electrical signal; an electrical circuit in said sense signal generator, said electrical circuit being connected to an electrical sensing component at said catheter distal end and adapted to generate an electrical sense signal corresponding to a physiological condition to be sensed by said sensing component; and said electrical circuit being connected to provide said electrical sense signal to said optical modulator in order to modulate said diverted light output into a sensing optical signal.
12. A photonic pacemaker in accordance with Claim 11, wherein said optical unit comprises an optical homogenizer.
13. A photonic pacemaker in accordance with Claim 11, wherein said optical unit comprises a prismatic optical homogenizer having a first end adapted to receive said light input and a second end having a partially reflective coating thereon for reflecting said second portion of said light input to said first end.
14. A photonic pacemaker in accordance with Claim 13, wherein said partially reflective coating comprises a partially reflective material covering all of said second end.
15. A photonic pacemaker in accordance with Claim 11, wherein said partially reflective coating comprises a fully reflective material covering a peripheral portion of said second end while leaving uncovered a central portion of said second end for transmitting said second portion of said light input.
16. A photonic pacemaker in accordance with Claim 11, wherein said optical modulator comprises a crystalline material having electrically controllable optical properties.
17. A photonic pacemaker in accordance with Claim 16, wherein said crystalline material is selected from the group consisting of lithium niobate, indium phosphide and gallium arsenide.
18. A photonic pacemaker in accordance with Claim 11, wherein said electrical circuit comprises means for conditioning a physiological sense signal generated via interaction of said sensing component with body tissue into said electrical sense signal.
19. A photonic pacemaker in accordance with Claim 11, wherein said electrical circuit comprises means for obtaining electrical power from said transmitted light output.
20. An optical sense signal generator in accordance with Claim 11, wherein said electrical circuit comprises means for converting said electrical sense signal from analog to digital form.
21. An opto-electric medical stimulation and sensing system having a photonic catheter containing one or more optical conductors for conducting light energy in two directions between electronics at a proximal end of said catheter and electrical stimulation and sensing components at a distal end of said catheter, comprising: an optical sense signal generator located at said catheter distal end; an optical unit in said sense signal generator adapted to receive a light input delivered from said catheter proximal end by one of said optical conductors and to transmit a first portion of said light input as a transmitted light output to an opto-electrical converter for conversion into electrical stimulation signals while diverting a second portion of said light input as a diverted light output; an optical modulator in said sense signal generator positioned to receive said diverted light output and being adapted to modulate said diverted light output under an applied electrical signal; an electrical circuit in said sense signal generator, said electrical circuit being connected to an electrical sensing component at said catheter distal end and adapted to generate an electrical sense signal corresponding to a physiological condition to be sensed by said sensing component; and said electrical circuit being connected to provide said electrical sense signal to said 5 optical modulator in order to modulate said reflected light output into a sensing optical signal.
22. A photonic pacemaker in accordance with Claim 21, wherein said optical unit comprises an optical homogenizer.
-10 23. A photonic pacemaker in accordance with Claim 21, wherein said optical unit comprises a prismatic optical homogenizer having a first end adapted to receive said light input and a second end having a partially reflective coating thereon for reflecting said second portion of said light input to said first end.
15 24. A photonic pacemaker in accordance with Claim 23, wherein said partially reflective coating comprises a partially reflective material covering all of said second end.
25. A photonic pacemaker in accordance with Claim 21, wherein said partially reflective coating comprises a fully reflective material covering a peripheral portion of said
20 second end while leaving uncovered a central portion of said second end for transmitting said second portion of said light input.
26. A photonic pacemaker in accordance with Claim 21, wherein said optical modulator comprises a crystalline material having electrically controllable optical properties.
25
27. A photonic pacemaker in accordance with Claim 26, wherein said crystalline material is selected from the group consisting of lithium niobate, indium phosphide and gallium arsenide.
30 28. A photonic pacemaker in accordance with Claim 21, wherein said electrical circuit comprises means for conditioning a physiological sense signal generated via interaction of said sensing component with body tissue into said electrical sense signal.
29. A photonic pacemaker in accordance with Claim 21, wherein said electrical circuit comprises means for obtaining electrical power from said transmitted light output.
30. An optical sense signal generator in accordance with Claim 21, wherein said electrical circuit comprises means for converting said electrical sense signal from analog to digital form.
31. An optical device adapted to operate at the distal end of a photonic catheter having one or more optical conductors for conducting light energy in two directions between electronics at a proximal end of the photonic catheter and electrical components at the distal end of the photonic catheter, comprising: an opto-electrical converter to convert received light into electrical signals; an optical unit adapted to receive light delivered from the proximal end of the photonic catheter via an optical conductor; said optical unit transmitting a first portion of the received light as transmitted light out to said opto-electrical converter while substantially simultaneously diverting a second portion of the received light; an optical modulator positioned to receive the light diverted by said optical unit; and a sensor, operatively connected to said optical modulator, to generate a physiological sense signal conesponding to a sensed physiological condition; and said optical modulator modulating the diverted light based upon the physiological sense signal generated by said sensor.
32. An optical device in accordance with Claim 31, wherein said optical unit comprises an optical homogenizer.
33. An optical device in accordance with Claim 31, wherein said optical unit comprises a prismatic optical homogenizer having a first end adapted to receive the light and a second end having a partially reflective coating thereon for reflecting a portion of the light to said first end.
34. An optical device in accordance with Claim 33, wherein said partially reflective coating comprises a partially reflective material covering all of said second end.
35. An optical device in accordance with Claim 31, wherein said partially reflective coating comprises a fully reflective material covering a peripheral portion of said second end while leaving uncovered a central portion of said second end for transmitting a portion of the light.
36. An optical device in accordance with Claim 31, wherein said optical modulator comprises a crystalline material having electrically controllable optical properties.
37. An optical device in accordance with Claim 36, wherein said crystalline material is selected from the group consisting of lithium niobate, indium phosphide, and gallium arsenide.
38. An optical device in accordance with Claim 31, wherein said sensor comprises means for conditioning the generated physiological sense signal.
39. An optical device in accordance with Claim 31, wherein said sensor is operatively coimected to said opto-electrcal converter to receive electrical power therefrom.
40. An optical sense device in accordance with Claim 31, wherein said sensor comprises means for converting the generated physiological sense signal into a digital signal.
PCT/US2003/010838 2002-04-11 2003-04-09 Mri-compatible medical device with passive generation of optical sensing signals WO2003086538A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003228475A AU2003228475A1 (en) 2002-04-11 2003-04-09 Mri-compatible medical device with passive generation of optical sensing signals

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/120,922 2002-04-11
US10/120,922 US6711440B2 (en) 2002-04-11 2002-04-11 MRI-compatible medical device with passive generation of optical sensing signals

Publications (1)

Publication Number Publication Date
WO2003086538A1 true WO2003086538A1 (en) 2003-10-23

Family

ID=28790204

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/010838 WO2003086538A1 (en) 2002-04-11 2003-04-09 Mri-compatible medical device with passive generation of optical sensing signals

Country Status (3)

Country Link
US (1) US6711440B2 (en)
AU (1) AU2003228475A1 (en)
WO (1) WO2003086538A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8543207B2 (en) 2004-12-17 2013-09-24 Cardiac Pacemakers, Inc. MRI operation modes for implantable medical devices
US8554335B2 (en) 2007-12-06 2013-10-08 Cardiac Pacemakers, Inc. Method and apparatus for disconnecting the tip electrode during MRI
US8565874B2 (en) 2009-12-08 2013-10-22 Cardiac Pacemakers, Inc. Implantable medical device with automatic tachycardia detection and control in MRI environments
US8897875B2 (en) 2007-12-06 2014-11-25 Cardiac Pacemakers, Inc. Selectively connecting the tip electrode during therapy for MRI shielding
US8977356B2 (en) 2009-02-19 2015-03-10 Cardiac Pacemakers, Inc. Systems and methods for providing arrhythmia therapy in MRI environments
WO2016131492A1 (en) * 2015-02-20 2016-08-25 Synergia Medical Photovoltaic electrical stimulation device
US9561378B2 (en) 2008-10-02 2017-02-07 Cardiac Pacemakers, Inc. Implantable medical device responsive to MRI induced capture threshold changes

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7415066B2 (en) * 1998-08-10 2008-08-19 Kamilo Feher Mis-matched modulation-demodulation format selectable filters
US6470055B1 (en) 1998-08-10 2002-10-22 Kamilo Feher Spectrally efficient FQPSK, FGMSK, and FQAM for enhanced performance CDMA, TDMA, GSM, OFDN, and other systems
US7548787B2 (en) * 2005-08-03 2009-06-16 Kamilo Feher Medical diagnostic and communication system
US7593481B2 (en) * 1998-08-31 2009-09-22 Kamilo Feher CDMA, W-CDMA, 3rd generation interoperable modem format selectable (MFS) systems with GMSK modulated systems
US6757334B1 (en) * 1998-08-10 2004-06-29 Kamilo Feher Bit rate agile third-generation wireless CDMA, GSM, TDMA and OFDM system
US8050345B1 (en) 1999-08-09 2011-11-01 Kamilo Feher QAM and GMSK systems
US7079584B2 (en) * 1998-08-10 2006-07-18 Kamilo Feher OFDM, CDMA, spread spectrum, TDMA, cross-correlated and filtered modulation
EP1110356A4 (en) 1998-08-31 2003-05-28 Kamilo Feher Feher keying (fk) modulation and transceivers including clock shaping processors
US9373251B2 (en) 1999-08-09 2016-06-21 Kamilo Feher Base station devices and automobile wireless communication systems
US9307407B1 (en) 1999-08-09 2016-04-05 Kamilo Feher DNA and fingerprint authentication of mobile devices
US7260369B2 (en) 2005-08-03 2007-08-21 Kamilo Feher Location finder, tracker, communication and remote control system
US9813270B2 (en) 1999-08-09 2017-11-07 Kamilo Feher Heart rate sensor and medical diagnostics wireless devices
US7428436B2 (en) * 2000-11-02 2008-09-23 Cardiac Pacemakers, Inc. Method for exclusion of ectopic events from heart rate variability metrics
US6949929B2 (en) * 2003-06-24 2005-09-27 Biophan Technologies, Inc. Magnetic resonance imaging interference immune device
AU2003239957A1 (en) * 2002-06-04 2003-12-19 Cyberkinetics, Inc. Optically-connected implants and related systems and methods of use
JP2004175052A (en) * 2002-11-29 2004-06-24 Sony Corp Medium to be recorded by ink jetting, ink jet imaging method, and printed matter
US7671594B2 (en) * 2003-06-24 2010-03-02 Medtronic, Inc. Magnetic resonance imaging interference immune device
US7839146B2 (en) * 2003-06-24 2010-11-23 Medtronic, Inc. Magnetic resonance imaging interference immune device
US20050070972A1 (en) * 2003-09-26 2005-03-31 Wahlstrand Carl D. Energy shunt for producing an MRI-safe implantable medical device
WO2005062823A2 (en) * 2003-12-19 2005-07-14 Savacor, Inc. Digital electrode for cardiac rhythm management
US7844344B2 (en) 2004-03-30 2010-11-30 Medtronic, Inc. MRI-safe implantable lead
US7844343B2 (en) * 2004-03-30 2010-11-30 Medtronic, Inc. MRI-safe implantable medical device
US7174219B2 (en) * 2004-03-30 2007-02-06 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US8989840B2 (en) * 2004-03-30 2015-03-24 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US7877150B2 (en) * 2004-03-30 2011-01-25 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US9155877B2 (en) * 2004-03-30 2015-10-13 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US20070280850A1 (en) * 2004-09-27 2007-12-06 Carlson James M Mri Compatible Devices
US7359449B2 (en) * 2004-10-05 2008-04-15 Kamilo Feher Data communication for wired and wireless communication
US7421004B2 (en) * 2004-10-05 2008-09-02 Kamilo Feher Broadband, ultra wideband and ultra narrowband reconfigurable interoperable systems
US20060149324A1 (en) * 2004-12-30 2006-07-06 Brian Mann Cardiac rhythm management with interchangeable components
US20060149330A1 (en) * 2004-12-30 2006-07-06 Brian Mann Digitally controlled cardiac rhythm management
US8280526B2 (en) * 2005-02-01 2012-10-02 Medtronic, Inc. Extensible implantable medical lead
US8066759B2 (en) * 2005-02-04 2011-11-29 Boston Scientific Scimed, Inc. Resonator for medical device
US7962208B2 (en) 2005-04-25 2011-06-14 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US8027736B2 (en) * 2005-04-29 2011-09-27 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US7853332B2 (en) * 2005-04-29 2010-12-14 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US8165693B2 (en) 2005-07-21 2012-04-24 Cyberonics, Inc. Safe-mode implantable medical devices
US7279664B2 (en) * 2005-07-26 2007-10-09 Boston Scientific Scimed, Inc. Resonator for medical device
US10009956B1 (en) 2017-09-02 2018-06-26 Kamilo Feher OFDM, 3G and 4G cellular multimode systems and wireless mobile networks
US7280810B2 (en) * 2005-08-03 2007-10-09 Kamilo Feher Multimode communication system
US7304277B2 (en) * 2005-08-23 2007-12-04 Boston Scientific Scimed, Inc Resonator with adjustable capacitor for medical device
US7524282B2 (en) * 2005-08-29 2009-04-28 Boston Scientific Scimed, Inc. Cardiac sleeve apparatus, system and method of use
US20090264732A1 (en) * 2005-10-11 2009-10-22 Huntington Medical Research Institutes Imaging agents and methods of use thereof
US8457742B2 (en) * 2005-10-14 2013-06-04 Nanostim, Inc. Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US9168383B2 (en) 2005-10-14 2015-10-27 Pacesetter, Inc. Leadless cardiac pacemaker with conducted communication
US7423496B2 (en) * 2005-11-09 2008-09-09 Boston Scientific Scimed, Inc. Resonator with adjustable capacitance for medical device
US7885710B2 (en) * 2005-12-23 2011-02-08 Cardiac Pacemakers, Inc. Method and apparatus for tissue protection against ischemia using remote conditioning
US7974697B2 (en) 2006-01-26 2011-07-05 Cyberonics, Inc. Medical imaging feedback for an implantable medical device
US8180462B2 (en) * 2006-04-18 2012-05-15 Cyberonics, Inc. Heat dissipation for a lead assembly
US8478420B2 (en) * 2006-07-12 2013-07-02 Cyberonics, Inc. Implantable medical device charge balance assessment
US20080027524A1 (en) * 2006-07-26 2008-01-31 Maschino Steven E Multi-electrode assembly for an implantable medical device
US8290592B2 (en) * 2006-09-21 2012-10-16 Cardiac Pacemakers, Inc. Implantable medical device header with optical interface
EP2117607A4 (en) 2007-01-11 2012-08-08 Huntington Medical Res Inst Imaging agents and methods of use thereof
US7974707B2 (en) * 2007-01-26 2011-07-05 Cyberonics, Inc. Electrode assembly with fibers for a medical device
US10537730B2 (en) * 2007-02-14 2020-01-21 Medtronic, Inc. Continuous conductive materials for electromagnetic shielding
US9044593B2 (en) * 2007-02-14 2015-06-02 Medtronic, Inc. Discontinuous conductive filler polymer-matrix composites for electromagnetic shielding
US8483842B2 (en) 2007-04-25 2013-07-09 Medtronic, Inc. Lead or lead extension having a conductive body and conductive body contact
WO2009039400A1 (en) * 2007-09-20 2009-03-26 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
US20100233089A1 (en) * 2007-10-05 2010-09-16 Huntington Medical Research Institutes Imaging of genetic material with magnetic resonance
US8868203B2 (en) 2007-10-26 2014-10-21 Cyberonics, Inc. Dynamic lead condition detection for an implantable medical device
US8942798B2 (en) 2007-10-26 2015-01-27 Cyberonics, Inc. Alternative operation mode for an implantable medical device based upon lead condition
US8311637B2 (en) 2008-02-11 2012-11-13 Cardiac Pacemakers, Inc. Magnetic core flux canceling of ferrites in MRI
US8160717B2 (en) 2008-02-19 2012-04-17 Cardiac Pacemakers, Inc. Model reference identification and cancellation of magnetically-induced voltages in a gradient magnetic field
US9037263B2 (en) 2008-03-12 2015-05-19 Medtronic, Inc. System and method for implantable medical device lead shielding
WO2009129265A1 (en) * 2008-04-14 2009-10-22 Huntington Medical Research Institutes Methods and apparatus for pasadena hyperpolarization
US20090318984A1 (en) * 2008-06-19 2009-12-24 Mokelke Eric A External pacemaker with automatic cardioprotective pacing protocol
US8457738B2 (en) * 2008-06-19 2013-06-04 Cardiac Pacemakers, Inc. Pacing catheter for access to multiple vessels
US9409012B2 (en) * 2008-06-19 2016-08-09 Cardiac Pacemakers, Inc. Pacemaker integrated with vascular intervention catheter
US9037235B2 (en) 2008-06-19 2015-05-19 Cardiac Pacemakers, Inc. Pacing catheter with expandable distal end
US20090318994A1 (en) * 2008-06-19 2009-12-24 Tracee Eidenschink Transvascular balloon catheter with pacing electrodes on shaft
US20090318749A1 (en) * 2008-06-19 2009-12-24 Craig Stolen Method and apparatus for pacing and intermittent ischemia
US8639357B2 (en) * 2008-06-19 2014-01-28 Cardiac Pacemakers, Inc. Pacing catheter with stent electrode
US8244352B2 (en) 2008-06-19 2012-08-14 Cardiac Pacemakers, Inc. Pacing catheter releasing conductive liquid
US8170661B2 (en) * 2008-07-01 2012-05-01 Cardiac Pacemakers, Inc. Pacing system controller integrated into indeflator
US20100056858A1 (en) * 2008-09-02 2010-03-04 Mokelke Eric A Pacing system for use during cardiac catheterization or surgery
US8527068B2 (en) 2009-02-02 2013-09-03 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
KR101051026B1 (en) * 2009-02-23 2011-07-26 한국과학기술연구원 Biostimulation device
EP2429630B1 (en) 2009-04-30 2017-10-25 Medtronic, Inc A shielded implantable medical lead with reduced torsional stiffness
EP2338564B1 (en) * 2009-12-22 2013-03-27 BIOTRONIK CRM Patent AG MRI optocoupler
US20110224606A1 (en) * 2010-03-10 2011-09-15 Shibaji Shome Method and apparatus for remote ischemic conditioning during revascularization
US8478428B2 (en) 2010-04-23 2013-07-02 Cyberonics, Inc. Helical electrode for nerve stimulation
US9060692B2 (en) 2010-10-12 2015-06-23 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
CN103249452A (en) 2010-10-12 2013-08-14 内诺斯蒂姆股份有限公司 Temperature sensor for a leadless cardiac pacemaker
US9020611B2 (en) 2010-10-13 2015-04-28 Pacesetter, Inc. Leadless cardiac pacemaker with anti-unscrewing feature
US8615310B2 (en) 2010-12-13 2013-12-24 Pacesetter, Inc. Delivery catheter systems and methods
US9126032B2 (en) 2010-12-13 2015-09-08 Pacesetter, Inc. Pacemaker retrieval systems and methods
EP2654889B1 (en) 2010-12-20 2017-03-01 Pacesetter, Inc. Leadless pacemaker with radial fixation mechanism
US8600334B2 (en) * 2011-07-13 2013-12-03 Biosense Webster (Israel), Ltd. Patient leakage current limitation
US9511236B2 (en) 2011-11-04 2016-12-06 Pacesetter, Inc. Leadless cardiac pacemaker with integral battery and redundant welds
WO2013158189A1 (en) 2012-04-19 2013-10-24 Medtronic, Inc. Paired medical lead bodies with braided conductive shields having different physical parameter values
EP2879758B1 (en) 2012-08-01 2018-04-18 Pacesetter, Inc. Biostimulator circuit with flying cell
US10649053B2 (en) * 2012-11-02 2020-05-12 The Regents Of The University Of California Cardiac late gadolinium enhancement MRI for patients with implanted cardiac devices
WO2014179890A1 (en) * 2013-05-09 2014-11-13 Sunnybrook Research Institute Systems and methods for providing visual feedback of touch panel input during magnetic resonance imaging
US9993638B2 (en) 2013-12-14 2018-06-12 Medtronic, Inc. Devices, systems and methods to reduce coupling of a shield and a conductor within an implantable medical lead
US9999774B2 (en) * 2014-05-06 2018-06-19 Medtronic, Inc. Optical trigger for therapy delivery
WO2016014427A1 (en) 2014-07-23 2016-01-28 Medtronic, Inc. Methods of shielding implantable medical leads and implantable medical lead extensions
EP3191175B1 (en) 2014-07-24 2022-03-02 Medtronic, Inc. Apparatus for shielding implantable medical leads and lead extensions
GB2556295A (en) * 2015-07-23 2018-05-23 Nonin Medical Inc Monitoring and feedback for resuscitation
US9498300B1 (en) * 2015-07-30 2016-11-22 Novartis Ag Communication system for surgical devices
CN107490429A (en) * 2017-07-21 2017-12-19 国网上海市电力公司 A kind of anti-error excavation prior-warning device of underground cable
AU2017430127B2 (en) * 2017-08-31 2020-03-05 Synergia Medical Implantable electrode coupled to an optoelectronic device
CN108721781A (en) * 2018-06-29 2018-11-02 谭雄进 A kind of photoelectricity pace-making device assembly

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183796A1 (en) * 2001-02-20 2002-12-05 Connelly Patrick R. Electromagnetic interference immune tissue invasive system

Family Cites Families (266)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3057356A (en) 1960-07-22 1962-10-09 Wilson Greatbatch Inc Medical cardiac pacemaker
US3478746A (en) 1965-05-12 1969-11-18 Medtronic Inc Cardiac implantable demand pacemaker
US3669095A (en) 1966-08-25 1972-06-13 Tokyo Shibaura Electric Co Catheter-type semi-conductor radiation detector for insertion into a human body
US3508167A (en) 1968-06-28 1970-04-21 Mennen Greatbatch Electronics Pulse generator
US3654537A (en) 1970-04-29 1972-04-04 Westinghouse Electric Corp High efficiency power supply for charging capacitors in steps
US3686958A (en) 1971-02-22 1972-08-29 Ladd Res Ind Fiber optic pressure detector
US3718142A (en) 1971-04-23 1973-02-27 Medtronic Inc Electrically shielded, gas-permeable implantable electro-medical apparatus
US3789667A (en) 1972-02-14 1974-02-05 Ladd Res Ind Inc Fiber optic pressure detector
US3825015A (en) 1972-12-14 1974-07-23 American Optical Corp Single catheter for atrial and ventricular stimulation
SE406551B (en) 1974-05-07 1979-02-19 Seiko Instr & Electronics SYSTEM FOR DETECTING INFORMATION REGARDING THE ELECTROMOTOR POWER OF SERIES-PLACED BATTERIES IN A HEART STIMULATOR
US4012641A (en) 1975-12-05 1977-03-15 The United States Of America As Represented By The Secretary Of The Navy Portable pulsed signal generator
US4071032A (en) 1976-01-29 1978-01-31 Pacesetter Systems Inc. Implantable living tissue stimulators
US4091818A (en) 1976-08-03 1978-05-30 Research Corporation Cardiac pacing apparatus with electromagnetic interference protection
JPS5382980A (en) 1976-12-28 1978-07-21 Agency Of Ind Science & Technol Distribution type information transmission unit by multi point electric stimulas
US4200110A (en) 1977-11-28 1980-04-29 United States Of America Fiber optic pH probe
US4333053A (en) 1979-03-13 1982-06-01 Emi Limited Imaging systems
US4210029A (en) 1979-05-04 1980-07-01 Lad Research Industries, Inc. Differential fiber optic differential pressure sensor
US4379262A (en) 1979-08-10 1983-04-05 Picker International Limited Nuclear magnetic resonance systems
JPS56106663A (en) 1980-01-31 1981-08-25 Tokyo Shibaura Electric Co Transmitting medium for energy to organism buried device
US4325382A (en) 1980-05-15 1982-04-20 Memorial Hospital For Cancer And Allied Diseases Process and apparatus for the real time adaptive filtering of catheter pressure measurements
US4341221A (en) 1980-10-07 1982-07-27 Medtronic, Inc. Shielded recording electrode system
CA1176091A (en) 1981-06-17 1984-10-16 Charles D. Knipe Optical cable
US4491768A (en) 1981-11-04 1985-01-01 Eaton Corporation Pulse width modulation inverter with battery charger
US4450408A (en) 1981-12-11 1984-05-22 General Electric Company Low loss wide band front end for NMR receiver
US4476870A (en) 1982-03-30 1984-10-16 The United States Of America As Represented By The Department Of Health And Human Services Fiber optic PO.sbsb.2 probe
JPS59103644A (en) 1982-12-07 1984-06-15 オリンパス光学工業株式会社 Endoscope photographing apparatus
US4934785A (en) 1983-08-29 1990-06-19 American Telephone And Telegraph Company Optical fiber connector
DE3430625A1 (en) 1984-08-20 1986-02-27 Siemens AG, 1000 Berlin und 8000 München DEVICE FOR THE CORE SPIN TOMOGRAPHY
US4727874A (en) 1984-09-10 1988-03-01 C. R. Bard, Inc. Electrosurgical generator with high-frequency pulse width modulated feedback power control
US4611127A (en) 1984-09-20 1986-09-09 Telectronics N.V. Electronic sensor for static magnetic field
US4545381A (en) 1984-10-01 1985-10-08 Cordis Corporation Adapter for converting a metal encapsulated implantable cardiac pacer to an externally worn cardiac pacer
JPS61197336A (en) 1985-02-28 1986-09-01 Ricoh Co Ltd Copying machine
US4677471A (en) 1985-08-16 1987-06-30 Olympus Optical Co., Ltd. Endoscope
JPS6252443A (en) 1985-08-30 1987-03-07 Toshiba Corp Probe tuning circuit of mr apparatus
EP0236562B2 (en) 1985-12-11 2006-06-07 Telectronics N.V. Apparatus for cardiac pacing with detection of cardiac evoked potentials
US4800883A (en) 1986-04-02 1989-01-31 Intermedics, Inc. Apparatus for generating multiphasic defibrillation pulse waveform
US4719159A (en) 1986-05-19 1988-01-12 Eastman Kodak Company Sealed lithium battery
US4784461A (en) 1986-11-04 1988-11-15 Northern Telecom Limited Optical cable with improved strength
US5055810A (en) 1986-12-31 1991-10-08 Hughes Aircraft Company Ultra-high speed light activated microwave switch/modulation using photoreactive effect
JPS63270024A (en) 1987-04-27 1988-11-08 Olympus Optical Co Ltd Electronic endoscopic apparatus
US4903701A (en) 1987-06-05 1990-02-27 Medtronic, Inc. Oxygen sensing pacemaker
EP0301323B1 (en) 1987-07-27 1993-05-12 Siemens Aktiengesellschaft Catheter with a built-in probe for implantation in the heart
US4827906A (en) 1987-08-31 1989-05-09 Heineman Medical Research Center Apparatus and method for activating a pump in response to optical signals from a pacemaker
US4827934A (en) 1987-10-27 1989-05-09 Siemens-Pacesetter, Inc. Sensing margin detectors for implantable electromedical devices
US5010888A (en) 1988-03-25 1991-04-30 Arzco Medical Electronics, Inc. Method and apparatus for detection of posterior ischemia
US4880004A (en) 1988-06-07 1989-11-14 Intermedics, Inc. Implantable cardiac stimulator with automatic gain control and bandpass filtering in feedback loop
JP2671016B2 (en) 1988-07-08 1997-10-29 サージカル・レーザー・テクノロジーズ・インコーポレイテッド Laser treatment device for narrow path in living tissue
DE3831809A1 (en) 1988-09-19 1990-03-22 Funke Hermann DEVICE DETERMINED AT LEAST PARTLY IN THE LIVING BODY
US4911525A (en) 1988-10-05 1990-03-27 Hicks John W Optical communication cable
US5089697A (en) 1989-01-11 1992-02-18 Prohaska Otto J Fiber optic sensing device including pressure detection and human implantable construction
US5226210A (en) 1989-01-23 1993-07-13 Minnesota Mining And Manufacturing Company Method of forming metal fiber mat/polymer composite
US4991590A (en) 1989-01-30 1991-02-12 Martin Goffman Associates Fiber optic intravascular blood pressure transducer
US5348010A (en) 1989-02-24 1994-09-20 Medrea, Inc., Pennsylvania Corp., Pa. Intracavity probe and interface device for MRI imaging and spectroscopy
US4930521A (en) 1989-03-17 1990-06-05 Metzger William T Variable stiffness esophageal catheter
US5240004A (en) 1989-04-28 1993-08-31 Thomas Jefferson University Intravascular, ultrasonic imaging catheters and methods for making same
US5061680A (en) 1989-07-31 1991-10-29 Biomagnetic Technologies, Inc. Superconducting biomagnetometer with remote pickup coil
US5158932A (en) 1989-07-31 1992-10-27 Biomagnetic Technologies, Inc. Superconducting biomagnetometer with inductively coupled pickup coil
US4987897A (en) 1989-09-18 1991-01-29 Medtronic, Inc. Body bus medical device communication system
US5570671A (en) 1989-09-18 1996-11-05 The Research Foundation Of State University Of New York Method for positioning esophageal catheter for determining pressures associated with the left atrium
RU1785710C (en) 1989-10-06 1993-01-07 Vremennyj Nauchnyj Kollektiv O Microwave resonant therapeutic device
US5178149A (en) 1989-11-06 1993-01-12 Michael Imburgia Transesophageal probe having simultaneous pacing and echocardiographic capability, and method of diagnosing heart disease using same
US5985129A (en) 1989-12-14 1999-11-16 The Regents Of The University Of California Method for increasing the service life of an implantable sensor
US5108369A (en) 1990-03-15 1992-04-28 Diagnostic Devices Group, Limited Dual-diameter multifunction catheter
US5154387A (en) 1990-05-31 1992-10-13 Syncromed Corporation Method and apparatus for esophageal pacing
US5387232A (en) 1990-05-31 1995-02-07 Synchrotech Medical Corporation Method and apparatus for esophageal pacing
US5168871A (en) 1990-11-09 1992-12-08 Medtronic, Inc. Method and apparatus for processing quasi-transient telemetry signals in noisy environments
AU645848B2 (en) 1991-01-15 1994-01-27 Pacesetter Ab A system and method for post-processing intracardiac signals
US6134003A (en) 1991-04-29 2000-10-17 Massachusetts Institute Of Technology Method and apparatus for performing optical measurements using a fiber optic imaging guidewire, catheter or endoscope
US5214730A (en) 1991-05-13 1993-05-25 Nippon Telegraph And Telephone Corporation Multifiber optical connector plug with low reflection and low insertion loss
US5217010A (en) 1991-05-28 1993-06-08 The Johns Hopkins University Ecg amplifier and cardiac pacemaker for use during magnetic resonance imaging
US5267564A (en) 1991-06-14 1993-12-07 Siemens Pacesetter, Inc. Pacemaker lead for sensing a physiologic parameter of the body
US5951596A (en) 1991-07-01 1999-09-14 Laser Biotherapy Inc Biological tissue stimulation by optical energy
US5217009A (en) 1991-07-10 1993-06-08 Kronberg James W Compact biomedical pulsed signal generator for bone tissue stimulation
US5869412A (en) 1991-08-22 1999-02-09 Minnesota Mining & Manufacturing Co. Metal fibermat/polymer composite
EP0534782A1 (en) 1991-09-26 1993-03-31 Medtronic, Inc. Implantable medical device enclosure
US5464014A (en) 1991-10-03 1995-11-07 Sugan Company Limited Display device for bioelectrical and biophysical phenomena
US5243979A (en) 1991-11-15 1993-09-14 Medtronic, Inc. Method and apparatus for implementing activity sensing in a pulse generator
EP0677763B1 (en) 1991-11-18 1999-10-13 Sumitomo Electric Industries, Ltd. Optical connector connecting apparatus with matching agent coating mechanism
US5830209A (en) 1992-02-05 1998-11-03 Angeion Corporation Multi-fiber laser catheter
US5681575A (en) 1992-05-19 1997-10-28 Westaim Technologies Inc. Anti-microbial coating for medical devices
US5324310A (en) 1992-07-01 1994-06-28 Medtronic, Inc. Cardiac pacemaker with auto-capture function
US5265602A (en) 1992-07-13 1993-11-30 Medtronic, Inc. Ring-to-ring cardiac electrogram pacemaker
US5435308A (en) 1992-07-16 1995-07-25 Abbott Laboratories Multi-purpose multi-parameter cardiac catheter
WO1994004083A1 (en) 1992-08-26 1994-03-03 Advanced Interventional Systems Optical catheter with stranded fibers
EP0660715B1 (en) 1992-09-18 1997-12-29 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives as antiarrhythmic agents
KR0126247B1 (en) 1992-11-09 1997-12-26 Fujitsu Ltd Method of coupling optical parts and refractive index imaging material
EP0597463A3 (en) 1992-11-13 1996-11-06 Dornier Med Systems Inc Thermotherapiesonde.
US5330512A (en) 1992-12-28 1994-07-19 Cardiac Pacemakers, Inc. Electrode charge-neutral sensing of evoked ECG
US5387229A (en) 1993-01-21 1995-02-07 Pacesetter, Inc. Multi-sensor cardiac pacemaker with sensor event recording capability
FR2704131B1 (en) 1993-04-22 1995-06-30 Odam Sensor device for electrocardiogram.
KR100269825B1 (en) 1993-04-30 2000-10-16 미야즈 준이찌로 Optical connector and method thereof
US5420954A (en) 1993-05-24 1995-05-30 Photonics Research Incorporated Parallel optical interconnect
SE9301855D0 (en) 1993-06-01 1993-06-01 Siemens-Elema Ab MEDICAL SYSTEM
US6052613A (en) 1993-06-18 2000-04-18 Terumo Cardiovascular Systems Corporation Blood pressure transducer
US5370668A (en) 1993-06-22 1994-12-06 Medtronic, Inc. Fault-tolerant elective replacement indication for implantable medical device
US5523534A (en) 1993-06-28 1996-06-04 Vital Connections, Inc. Shielded carbon lead for medical electrodes
US5571088A (en) 1993-07-01 1996-11-05 Boston Scientific Corporation Ablation catheters
US6277107B1 (en) 1993-08-13 2001-08-21 Daig Corporation Guiding introducer for introducing medical devices into the coronary sinus and process for using same
US5410413A (en) 1993-08-18 1995-04-25 Petrometrix Ltd. Optical head probe using a gradient index lens and optical fibers
US5917625A (en) 1993-09-09 1999-06-29 Kabushiki Kaisha Toshiba High resolution optical multiplexing and demultiplexing device in optical communication system
US5626618A (en) 1993-09-24 1997-05-06 The Ohio State University Mechanical adjunct to cardiopulmonary resuscitation (CPR), and an electrical adjunct to defibrillation countershock, cardiac pacing, and cardiac monitoring
US5435316A (en) 1993-10-07 1995-07-25 Medtronic, Inc. Low amplitude pacing artifact detection amplifier circuit with driven right leg for filtering high frequency noise caused by multiple noise sources
FR2710848B1 (en) 1993-10-08 1995-12-01 Ela Medical Sa Implantable defibrillator with optically isolated shock generator.
JP3236716B2 (en) 1993-10-15 2001-12-10 富士写真光機株式会社 Shield structure of electronic endoscope device
US5492118A (en) 1993-12-16 1996-02-20 Board Of Trustees Of The University Of Illinois Determining material concentrations in tissues
SE513183C2 (en) 1994-03-18 2000-07-24 Ericsson Telefon Ab L M Process for producing an optocomponent and nested optocomponent
US5453838A (en) 1994-06-17 1995-09-26 Ceram Optec Industries, Inc. Sensing system with a multi-channel fiber optic bundle sensitive probe
US5445151A (en) 1994-06-23 1995-08-29 General Electric Company Method for blood flow acceleration and velocity measurement using MR catheters
US5716386A (en) 1994-06-27 1998-02-10 The Ohio State University Non-invasive aortic impingement and core and cerebral temperature manipulation
US5601611A (en) 1994-08-05 1997-02-11 Ventritex, Inc. Optical blood flow measurement apparatus and method and implantable defibrillator incorporating same
US5601615A (en) 1994-08-16 1997-02-11 Medtronic, Inc. Atrial and ventricular capture detection and threshold-seeking pacemaker
DE4431703C2 (en) 1994-09-06 1997-01-30 Itt Ind Gmbh Deutsche Magnetic field sensor with Hall element
GB2293248B (en) 1994-09-07 1998-02-18 Northern Telecom Ltd Providing optical coupling between optical components
SE9403188D0 (en) 1994-09-22 1994-09-22 Siemens Elema Ab Magnetic field detector on a medical implant
US6036654A (en) 1994-09-23 2000-03-14 Baxter International Inc. Multi-lumen, multi-parameter catheter
US5827997A (en) 1994-09-30 1998-10-27 Chung; Deborah D. L. Metal filaments for electromagnetic interference shielding
AU3299995A (en) 1994-10-04 1996-04-18 Medtronic, Inc. Protective feedthrough
US5520190A (en) 1994-10-31 1996-05-28 Ventritex, Inc. Cardiac blood flow sensor and method
US5582170A (en) 1994-12-01 1996-12-10 University Of Massachusetts Medical Center Fiber optic sensor for in vivo measurement of nitric oxide
FR2728799B1 (en) 1994-12-30 1997-03-28 Ela Medical Sa ACTIVE IMPLANTABLE DEVICE, IN PARTICULAR STIMULATOR OR CARDIAC DEFIBRILLATOR, PROVIDED WITH MEANS OF PROTECTION AGAINST ELECTROMAGNETIC DISTURBANCES OF EXTERNAL ORIGIN
US5836895A (en) 1995-01-09 1998-11-17 Arzco Medical Systems, Inc. Esophageal catheter with gauge
US5603697A (en) 1995-02-14 1997-02-18 Fidus Medical Technology Corporation Steering mechanism for catheters and methods for making same
US5699801A (en) 1995-06-01 1997-12-23 The Johns Hopkins University Method of internal magnetic resonance imaging and spectroscopic analysis and associated apparatus
US5749910A (en) 1995-06-07 1998-05-12 Angeion Corporation Shield for implantable cardioverter defibrillator
US5814090A (en) 1995-06-07 1998-09-29 Angeion Corporation Implantable medical device having heat-shrink conforming shield
US5697958A (en) 1995-06-07 1997-12-16 Intermedics, Inc. Electromagnetic noise detector for implantable medical devices
US5653735A (en) 1995-06-28 1997-08-05 Pacesetter, Inc. Implantable cardiac stimulation device having an improved backup mode of operation and method thereof
US5723856A (en) 1995-08-01 1998-03-03 California Institute Of Technology Opto-electronic oscillator having a positive feedback with an open loop gain greater than one
JPH0949947A (en) 1995-08-10 1997-02-18 Hitachi Ltd Optical module
WO1997012210A1 (en) 1995-09-29 1997-04-03 Swee Chuan Tjin Fiber optic catheter for accurate flow measurements
US5882108A (en) 1995-10-12 1999-03-16 Valeo Sylvania L.L.C. Lighting with EMI shielding
US5738105A (en) 1995-10-24 1998-04-14 Angeion Corporation Method and apparatus for sensing R-waves using both near field and far field sensing simultaneously
US5774501A (en) 1995-10-24 1998-06-30 Halpern, Deceased; Peter H. High speed multilevel symbol telemetry system for cardiac pacemakers
US5620476A (en) 1995-11-13 1997-04-15 Pacesetter, Inc. Implantable medical device having shielded and filtered feedthrough assembly and methods for making such assembly
US5733247A (en) 1995-12-20 1998-03-31 Hewlett-Packard Company MR compatible patient monitor
US5679026A (en) 1995-12-21 1997-10-21 Ventritex, Inc. Header adapter for an implantable cardiac stimulation device
US5868664A (en) 1996-02-23 1999-02-09 Envision Medical Corporation Electrically isolated sterilizable endoscopic video camera head
US5776167A (en) 1996-02-27 1998-07-07 Pacesetter, Inc. System and method for alleviating the effects of pacemaker crosstalk
SE9601155D0 (en) 1996-03-26 1996-03-26 Pacesetter Ab Device for active implant
WO1997035636A1 (en) 1996-03-28 1997-10-02 Medtronic, Inc. Detection of pressure waves transmitted through catheter/lead body
US5973779A (en) 1996-03-29 1999-10-26 Ansari; Rafat R. Fiber-optic imaging probe
US5776168A (en) 1996-04-03 1998-07-07 Medtronic, Inc. EGM recording system for implantable medical device
US5782880A (en) 1996-04-23 1998-07-21 Medtronic, Inc. Low energy pacing pulse waveform for implantable pacemaker
US5928145A (en) 1996-04-25 1999-07-27 The Johns Hopkins University Method of magnetic resonance imaging and spectroscopic analysis and associated apparatus employing a loopless antenna
US6263229B1 (en) 1998-11-13 2001-07-17 Johns Hopkins University School Of Medicine Miniature magnetic resonance catheter coils and related methods
US6006134A (en) 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US6005191A (en) 1996-05-02 1999-12-21 Parker-Hannifin Corporation Heat-shrinkable jacket for EMI shielding
US5817130A (en) 1996-05-03 1998-10-06 Sulzer Intermedics Inc. Implantable cardiac cardioverter/defibrillator with EMI suppression filter with independent ground connection
US5611016A (en) 1996-06-07 1997-03-11 Lucent Technologies Inc. Dispersion-balanced optical cable
WO1998010303A1 (en) 1996-09-02 1998-03-12 Philips Electronics N.V. Invasive device for use in a magnetic resonance imaging apparatus
US5730134A (en) 1996-09-09 1998-03-24 General Electric Company System to monitor temperature near an invasive device during magnetic resonance procedures
US5963034A (en) 1996-09-19 1999-10-05 Ramar Corporation Electro-optic electromagnetic field sensor system with optical bias adjustment
US5755742A (en) 1996-11-05 1998-05-26 Medtronic, Inc. Cardioversion/defibrillation lead impedance measurement system
US6119031A (en) 1996-11-21 2000-09-12 Boston Scientific Corporation Miniature spectrometer
US5755739A (en) 1996-12-04 1998-05-26 Medtronic, Inc. Adaptive and morphological system for discriminating P-waves and R-waves inside the human body
DE69736826T2 (en) 1996-12-05 2007-05-16 Philips Medical Systems (Cleveland), Inc., Cleveland Radio frequency coils for nuclear resonance
US5999857A (en) 1996-12-18 1999-12-07 Medtronic, Inc. Implantable device telemetry system and method
US5814089A (en) 1996-12-18 1998-09-29 Medtronic, Inc. Leadless multisite implantable stimulus and diagnostic system
US5814087A (en) 1996-12-18 1998-09-29 Medtronic, Inc. Rate responsive pacemaker adapted to adjust lower rate limit according to monitored patient blood temperature
US5895980A (en) 1996-12-30 1999-04-20 Medical Pacing Concepts, Ltd. Shielded pacemaker enclosure
US5865839A (en) 1996-12-30 1999-02-02 Doorish; John F. Artificial retina
US6055455A (en) 1997-01-06 2000-04-25 Cardiac Pacemakers, Inc. Filtered feedthrough for an implantable medical device
FR2758221B1 (en) 1997-01-07 1999-03-26 Ela Medical Sa DEVICE FOR FILTERING HEART ACTIVITY SIGNALS
JP3515305B2 (en) 1997-01-16 2004-04-05 株式会社フジクラ Optical connector
US5982961A (en) 1997-01-21 1999-11-09 Molecular Optoelectronics Corporation Organic crystal compound optical waveguide and methods for its fabrication
NL1005068C2 (en) 1997-01-23 1998-07-27 Ct Rrn Academisch Ziekenhuis U Catheter system and a catheter forming part thereof.
US5928569A (en) 1997-02-26 1999-07-27 Specialty Silicone Products, Inc. Substantially uniform moldable blends of silver particulate and organopolysiloxane
US5919135A (en) 1997-02-28 1999-07-06 Lemelson; Jerome System and method for treating cellular disorders in a living being
US5766227A (en) 1997-03-04 1998-06-16 Nappholz; Tibor A. EMI detection in an implantable pacemaker and the like
US5817133A (en) 1997-03-04 1998-10-06 Medtronic, Inc. Pacemaker with morphological filtering of sensed cardiac signals
US6067472A (en) 1997-03-12 2000-05-23 Medtronic, Inc. Pacemaker system and method with improved evoked response and repolarization signal detection
US6275730B1 (en) 1997-03-14 2001-08-14 Uab Research Foundation Method and apparatus for treating cardiac arrythmia
US6266563B1 (en) 1997-03-14 2001-07-24 Uab Research Foundation Method and apparatus for treating cardiac arrhythmia
US5772604A (en) 1997-03-14 1998-06-30 Emory University Method, system and apparatus for determining prognosis in atrial fibrillation
US6173203B1 (en) 1997-04-08 2001-01-09 Survivalink Corpration Circuit mounting system for automated external defibrillator circuits
US5808730A (en) 1997-04-08 1998-09-15 Ceramoptec Industries Inc. Fiber optic displacement sensor
US6036639A (en) 1997-04-11 2000-03-14 Minrad Inc. Laryngoscope having low magnetic susceptibility and method of assembling
US6056415A (en) 1997-04-11 2000-05-02 Minrad Inc. Penlight having low magnetic susceptibility
US5752977A (en) 1997-04-15 1998-05-19 Medtronic, Inc. Efficient high data rate telemetry format for implanted medical device
US5873898A (en) 1997-04-29 1999-02-23 Medtronic, Inc. Microprocessor capture detection circuit and method
US6198972B1 (en) 1997-04-30 2001-03-06 Medtronic, Inc. Control of externally induced current in implantable medical devices
US6278057B1 (en) 1997-05-02 2001-08-21 General Science And Technology Corp. Medical devices incorporating at least one element made from a plurality of twisted and drawn wires at least one of the wires being a nickel-titanium alloy wire
US5817136A (en) 1997-05-02 1998-10-06 Pacesetter, Inc. Rate-responsive pacemaker with minute volume determination and EMI protection
US5870272A (en) 1997-05-06 1999-02-09 Medtronic Inc. Capacitive filter feedthrough for implantable medical device
US5827195A (en) 1997-05-09 1998-10-27 Cambridge Heart, Inc. Electrocardiogram noise reduction using multi-dimensional filtering
US6026316A (en) 1997-05-15 2000-02-15 Regents Of The University Of Minnesota Method and apparatus for use with MR imaging
US5940554A (en) 1997-05-23 1999-08-17 Lightwave Link, Inc. Fiber optic coupling apparatus and method
ES2129361B1 (en) 1997-05-28 1999-12-16 Univ Madrid Politecnica PHOTOVOLTAIC TELEALIMENTATION SYSTEM THROUGH FIBER OPTICS FOR IMPLANTABLE MEDICAL DEVICES.
US6090473A (en) 1997-06-24 2000-07-18 Bridgestone Corporation Electromagnetic-wave shielding and light transmitting plate
US6296654B1 (en) 1997-06-27 2001-10-02 The Ohio State University Research Foundation Non-invasive aortic impingement
US5987995A (en) 1997-07-17 1999-11-23 Sentec Corporation Fiber optic pressure catheter
US6056721A (en) 1997-08-08 2000-05-02 Sunscope International, Inc. Balloon catheter and method
US6076003A (en) 1998-05-01 2000-06-13 R.Z. Comparative Diagnostics Ltd. Electrocardiography electrodes holder and monitoring set
US6144866A (en) 1998-10-30 2000-11-07 Medtronic, Inc. Multiple sensor assembly for medical electric lead
US6049736A (en) 1997-09-03 2000-04-11 Medtronic, Inc. Implantable medical device with electrode lead having improved surface characteristics
US5902326A (en) 1997-09-03 1999-05-11 Medtronic, Inc. Optical window for implantable medical devices
US6052614A (en) 1997-09-12 2000-04-18 Magnetic Resonance Equipment Corp. Electrocardiograph sensor and sensor control system for use with magnetic resonance imaging machines
US6011994A (en) 1997-09-24 2000-01-04 Equitech Intl' Corporation Multipurpose biomedical pulsed signal generator
US5967977A (en) 1997-10-03 1999-10-19 Medtronic, Inc. Transesophageal medical lead
GB2330202A (en) 1997-10-07 1999-04-14 Marconi Gec Ltd Flexible MRI antenna for intra-cavity use
US5891171A (en) 1997-10-22 1999-04-06 Pacesetter Incorporated Apparatus with noise classification in an implantable cardiac device by using an amplifier with a variable threshold
US5897577A (en) 1997-11-07 1999-04-27 Medtronic, Inc. Pacing lead impedance monitoring circuit and method
US5968083A (en) 1997-11-12 1999-10-19 Pacesetter, Inc. Active overload detection and protection circuit for implantable cardiac therapy devices
US5928270A (en) 1997-12-02 1999-07-27 Cardiocommand, Inc. Method and apparatus for incremental cardioversion or defibrillation
SE9704520D0 (en) 1997-12-04 1997-12-04 Pacesetter Ab Pacemaker
US6013376A (en) 1997-12-09 2000-01-11 3M Innovative Properties Company Metal fibermat/polymer composite
US5946086A (en) 1997-12-10 1999-08-31 Northern Telecom Limited Optical mean power controller with provisionable output levels
US6016477A (en) 1997-12-18 2000-01-18 International Business Machines Corporation Method and apparatus for identifying applicable business rules
US6091744A (en) 1998-01-14 2000-07-18 Hewlett-Packard Company Wavelength selectable source for wavelength division multiplexed applications
US5963690A (en) 1998-01-20 1999-10-05 Cheng; Yu-Feng Optical fiber connector
US5978710A (en) 1998-01-23 1999-11-02 Sulzer Intermedics Inc. Implantable cardiac stimulator with safe noise mode
WO1999037211A1 (en) 1998-01-26 1999-07-29 Scimed Life Systems, Inc. Catheter assembly with distal end inductive coupler and embedded transmission line
US6258087B1 (en) 1998-02-19 2001-07-10 Curon Medical, Inc. Expandable electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions
US5999853A (en) 1998-03-02 1999-12-07 Vitatron Medical, B.V. Dual chamber pacemaker with single pass lead and with bipolar and unipolar signal processing capability
US5973906A (en) 1998-03-17 1999-10-26 Maxwell Energy Products, Inc. Chip capacitors and chip capacitor electromagnetic interference filters
US5871509A (en) 1998-04-02 1999-02-16 Pacesetter Ab Method and apparatus to remove data outliers, produced by external disturbance, in internally measured signals in an implantable cardiac stimulator
US6256541B1 (en) 1998-04-17 2001-07-03 Cardiac Pacemakers, Inc. Endocardial lead having defibrillation and sensing electrodes with septal anchoring
US6023641A (en) 1998-04-29 2000-02-08 Medtronic, Inc. Power consumption reduction in medical devices employing multiple digital signal processors
US6070102A (en) 1998-04-29 2000-05-30 Medtronic, Inc. Audible sound confirmation of programming an implantable medical device
US6082367A (en) 1998-04-29 2000-07-04 Medtronic, Inc. Audible sound communication from an implantable medical device
US6091987A (en) 1998-04-29 2000-07-18 Medtronic, Inc. Power consumption reduction in medical devices by employing different supply voltages
US6270831B2 (en) 1998-04-30 2001-08-07 Medquest Products, Inc. Method and apparatus for providing a conductive, amorphous non-stick coating
US5916237A (en) 1998-04-30 1999-06-29 Medtronic, Inc. Power control apparatus and method for a body implantable medical device
US6090728A (en) 1998-05-01 2000-07-18 3M Innovative Properties Company EMI shielding enclosures
US5957857A (en) 1998-05-07 1999-09-28 Cardiac Pacemakers, Inc. Apparatus and method for automatic sensing threshold determination in cardiac pacemakers
US6266555B1 (en) 1998-05-07 2001-07-24 Medtronic, Inc. Single complex electrogram display having a sensing threshold for an implantable medical device
US6066096A (en) 1998-05-08 2000-05-23 Duke University Imaging probes and catheters for volumetric intraluminal ultrasound imaging and related systems
US6118910A (en) 1998-05-19 2000-09-12 Agilent Technologies, Inc. Method of aligning optical fibers to a multi-port optical assembly
US6134478A (en) 1998-06-05 2000-10-17 Intermedics Inc. Method for making cardiac leads with zone insulated electrodes
US6029086A (en) 1998-06-15 2000-02-22 Cardiac Pacemakers, Inc. Automatic threshold sensitivity adjustment for cardiac rhythm management devices
US6275732B1 (en) 1998-06-17 2001-08-14 Cardiac Pacemakers, Inc. Multiple stage morphology-based system detecting ventricular tachycardia and supraventricular tachycardia
US6080829A (en) 1998-06-24 2000-06-27 Medtronic, Inc. Silalkylenesiloxane copolymer materials and methods for their preparation
FR2780290B1 (en) 1998-06-26 2000-09-22 Ela Medical Sa ACTIVE IMPLANTABLE MEDICAL DEVICE SERVED AS A CARDIAC STIMULATOR, DEFIBRILLATOR AND / OR CARDIOVERTER, ESPECIALLY OF THE MULTI-SITE TYPE
US6148222A (en) 1998-07-10 2000-11-14 Cardiocommand, Inc. Esophageal catheters and method of use
DE19833350C1 (en) 1998-07-24 2000-03-09 Bruker Analytik Gmbh Sampling head used for taking NMR measurements includes a series condenser between high frequency line and measurement coil
US6163724A (en) 1998-09-18 2000-12-19 Medtronic, Inc. Microprocessor capture detection circuit and method
JP2000102137A (en) 1998-09-22 2000-04-07 Sumitomo Wiring Syst Ltd Optical cable, laying method thereof and wiring system using the same
US6029087A (en) 1998-09-22 2000-02-22 Vitatron Medical, B.V. Cardiac pacing system with improved physiological event classification based on DSP
US6129745A (en) 1998-10-23 2000-10-10 Medtronic, Inc. Medical device for automatic diagnosis of undersensing by timing
US6016448A (en) 1998-10-27 2000-01-18 Medtronic, Inc. Multilevel ERI for implantable medical devices
US6144205A (en) 1998-11-19 2000-11-07 General Electric Company Optical control of radio frequency antennae in a magnetic resonance imaging system
US6052623A (en) 1998-11-30 2000-04-18 Medtronic, Inc. Feedthrough assembly for implantable medical devices and methods for providing same
US6278897B1 (en) 1998-12-03 2001-08-21 Medtronic, Inc Medical electrical lead and introducer system
US6148229A (en) 1998-12-07 2000-11-14 Medrad, Inc. System and method for compensating for motion artifacts in a strong magnetic field
US6169921B1 (en) 1998-12-08 2001-01-02 Cardiac Pacemakers, Inc. Autocapture determination for an implantable cardioverter defibrillator
US6275734B1 (en) 1998-12-30 2001-08-14 Pacesetter, Inc. Efficient generation of sensing signals in an implantable medical device such as a pacemaker or ICD
US6149313A (en) 1998-12-31 2000-11-21 Siecor Operations, Llc Gender selectable fiber optic connector and associated fabrication method
US6317633B1 (en) 1999-01-19 2001-11-13 Medtronic, Inc. Implantable lead functional status monitor and method
US6259954B1 (en) 1999-02-18 2001-07-10 Intermedics Inc. Endocardial difibrillation lead with strain-relief coil connection
US6256537B1 (en) 1999-03-17 2001-07-03 Medtronic, Inc. Pacemaker system with inhibition of AV node for rate regulation during atrial fibrillation
US6263242B1 (en) 1999-03-25 2001-07-17 Impulse Dynamics N.V. Apparatus and method for timing the delivery of non-excitatory ETC signals to a heart
US6223083B1 (en) 1999-04-16 2001-04-24 Medtronic, Inc. Receiver employing digital filtering for use with an implantable medical device
US6240317B1 (en) 1999-04-30 2001-05-29 Medtronic, Inc. Telemetry system for implantable medical devices
US6146415A (en) 1999-05-07 2000-11-14 Advanced Cardiovascular Systems, Inc. Stent delivery system
US6266566B1 (en) 1999-05-21 2001-07-24 Medtronic, Inc. Waveform normalization in a medical device
US6270457B1 (en) 1999-06-03 2001-08-07 Cardiac Intelligence Corp. System and method for automated collection and analysis of regularly retrieved patient information for remote patient care
US6142678A (en) 1999-06-15 2000-11-07 Jds Uniphase Inc. Optical coupling
US6278894B1 (en) 1999-06-21 2001-08-21 Cardiac Pacemakers, Inc. Multi-site impedance sensor using coronary sinus/vein electrodes
US6274265B1 (en) 1999-07-21 2001-08-14 Medtronic, Inc. Method and system for evaluating an electrochemical cell for use with an implantable medical device
US6272380B1 (en) 1999-08-19 2001-08-07 Medtronic, Inc. Apparatus for treating atrial tachy arrhythmias with synchronized shocks
US6208899B1 (en) 1999-09-15 2001-03-27 Pacesetter, Inc. Implantable cardioversion device with automatic filter control
US6272377B1 (en) 1999-10-01 2001-08-07 Cardiac Pacemakers, Inc. Cardiac rhythm management system with arrhythmia prediction and prevention
US6230060B1 (en) 1999-10-22 2001-05-08 Daniel D. Mawhinney Single integrated structural unit for catheter incorporating a microwave antenna
US6367984B1 (en) 1999-11-10 2002-04-09 Lucent Technologies, Inc. Optical fiber adapter
US6277078B1 (en) 1999-11-19 2001-08-21 Remon Medical Technologies, Ltd. System and method for monitoring a parameter associated with the performance of a heart
US6254632B1 (en) 2000-09-28 2001-07-03 Advanced Cardiovascular Systems, Inc. Implantable medical device having protruding surface structures for drug delivery and cover attachment

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183796A1 (en) * 2001-02-20 2002-12-05 Connelly Patrick R. Electromagnetic interference immune tissue invasive system

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8543207B2 (en) 2004-12-17 2013-09-24 Cardiac Pacemakers, Inc. MRI operation modes for implantable medical devices
US8886317B2 (en) 2004-12-17 2014-11-11 Cardiac Pacemakers, Inc. MRI operation modes for implantable medical devices
US8554335B2 (en) 2007-12-06 2013-10-08 Cardiac Pacemakers, Inc. Method and apparatus for disconnecting the tip electrode during MRI
US8897875B2 (en) 2007-12-06 2014-11-25 Cardiac Pacemakers, Inc. Selectively connecting the tip electrode during therapy for MRI shielding
US9561378B2 (en) 2008-10-02 2017-02-07 Cardiac Pacemakers, Inc. Implantable medical device responsive to MRI induced capture threshold changes
US8977356B2 (en) 2009-02-19 2015-03-10 Cardiac Pacemakers, Inc. Systems and methods for providing arrhythmia therapy in MRI environments
US8565874B2 (en) 2009-12-08 2013-10-22 Cardiac Pacemakers, Inc. Implantable medical device with automatic tachycardia detection and control in MRI environments
US9381371B2 (en) 2009-12-08 2016-07-05 Cardiac Pacemakers, Inc. Implantable medical device with automatic tachycardia detection and control in MRI environments
WO2016131492A1 (en) * 2015-02-20 2016-08-25 Synergia Medical Photovoltaic electrical stimulation device
CN107249682A (en) * 2015-02-20 2017-10-13 赛纳吉亚医疗公司 Photovoltaic electrical stimulation apparatus
CN107249682B (en) * 2015-02-20 2018-10-12 赛纳吉亚医疗公司 Photovoltaic electrical stimulation apparatus
US10350424B2 (en) 2015-02-20 2019-07-16 Synergia Medical Photovoltaic electrical stimulation device

Also Published As

Publication number Publication date
US6711440B2 (en) 2004-03-23
AU2003228475A1 (en) 2003-10-27
US20030195570A1 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
US6711440B2 (en) MRI-compatible medical device with passive generation of optical sensing signals
US6725092B2 (en) Electromagnetic radiation immune medical assist device adapter
US20020116029A1 (en) MRI-compatible pacemaker with power carrying photonic catheter and isolated pulse generating electronics providing VOO functionality
US20020116034A1 (en) Controllable, wearable MRI-compatible pacemaker with power carrying photonic catheter and VOO functionality
US7450996B2 (en) Medical device with an electrically conductive anti-antenna geometrical shaped member
US7280870B2 (en) Optically-connected implants and related systems and methods of use
US20020116033A1 (en) Controllable, wearable MRI-compatible cardiac pacemaker with pulse carrying photonic catheter and VOO functionality
CN110785205B (en) Implantable electrode coupled to an optoelectronic device
US20030130701A1 (en) Opto-electric coupling device for photonic pacemakers and other opto-electric medical stimulation equipment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP